{
  "metadata": {
    "config": {
      "backend": {
        "_target_": "cotlab.backends.VLLMBackend",
        "tensor_parallel_size": 1,
        "dtype": "bfloat16",
        "trust_remote_code": true,
        "max_model_len": 4096
      },
      "model": {
        "name": "google/medgemma-4b-it",
        "variant": "4b",
        "max_new_tokens": 512,
        "temperature": 0.7,
        "top_p": 0.9,
        "safe_name": "medgemma_4b"
      },
      "prompt": {
        "_target_": "cotlab.prompts.OncologyPromptStrategy",
        "name": "oncology",
        "contrarian": false,
        "few_shot": true,
        "answer_first": false,
        "output_format": "json"
      },
      "dataset": {
        "_target_": "cotlab.datasets.OncologyDataset",
        "name": "oncology",
        "path": "data/oncology.json"
      },
      "experiment": {
        "_target_": "cotlab.experiments.RadiologyExperiment",
        "name": "radiology",
        "description": "Pathological fracture detection from radiology reports",
        "num_samples": -1
      },
      "seed": 42,
      "verbose": true,
      "dry_run": false
    },
    "start_time": "2026-01-10T18:23:05.973812"
  },
  "experiment": "radiology",
  "model": "google/medgemma-4b-it",
  "prompt_strategy": "oncology",
  "metrics": {
    "correct": 100,
    "incorrect": 0,
    "true_positives": 50,
    "true_negatives": 50,
    "false_positives": 0,
    "false_negatives": 0,
    "parse_errors": 0,
    "accuracy": 1.0,
    "parse_error_rate": 0.0,
    "precision": 1.0,
    "recall": 1.0,
    "f1": 1.0
  },
  "raw_outputs": [
    {
      "sample_idx": 0,
      "input": "02/01/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 02/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"normalized blood counts\", \"no organomegaly\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified, and that the patient is in clinical improvement.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"normalized blood counts\", \"no organomegaly\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified, and that the patient is in clinical improvement.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"normalized blood counts\", \"no organomegaly\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified, and that the patient is in clinical improvement.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"normalized blood counts\", \"no organomegaly\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified, and that the patient is in clinical improvement.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"normalized blood counts\", \"no organomegaly\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified, and that the patient is in clinical improvement.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"normalized blood counts\", \"no organomegaly\", \"no malignancy identified\"],",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that no malignancy was identified, and that the patient is in clinical improvement.",
      "findings": [
        "resolved febrile illness",
        "normalized blood counts",
        "no organomegaly",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 0,
      "timestamp": "2026-01-10T18:24:08.431990"
    },
    {
      "sample_idx": 1,
      "input": "26/10/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 26/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report explicitly states a posterior fossa mass with enhancement and hydrocephalus, restricted diffusion, and high-grade medulloblastoma on histology, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report explicitly states a posterior fossa mass with enhancement and hydrocephalus, restricted diffusion, and high-grade medulloblastoma on histology, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report explicitly states a posterior fossa mass with enhancement and hydrocephalus, restricted diffusion, and high-grade medulloblastoma on histology, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report explicitly states a posterior fossa mass with enhancement and hydrocephalus, restricted diffusion, and high-grade medulloblastoma on histology, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report explicitly states a posterior fossa mass with enhancement and hydrocephalus, restricted diffusion, and high-grade medullo",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly states a posterior fossa mass with enhancement and hydrocephalus, restricted diffusion, and high-grade medulloblastoma on histology, indicating malignancy.",
      "findings": [
        "posterior fossa mass with enhancement and hydrocephalus",
        "Restricted diffusion",
        "High-grade medulloblastoma on histology"
      ],
      "fracture_mentioned": null,
      "idx": 1,
      "timestamp": "2026-01-10T18:24:08.432015"
    },
    {
      "sample_idx": 2,
      "input": "03/07/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 03/07/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"node size decreasing on follow-up\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign condition. No atypical features or malignancy is identified, and the node size is decreasing on follow-up.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign condition. No atypical features or malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign condition. No atypical features or malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign condition. No atypical features or malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign condition. No atypical features or malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes reactive lymphadenopathy, which is a benign condition. No atypical features or malignancy is identified, and the node size is decreasing on follow-up.",
      "findings": [
        "reactive lymphadenopathy",
        "node size decreasing on follow-up",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 2,
      "timestamp": "2026-01-10T18:24:08.432030"
    },
    {
      "sample_idx": 3,
      "input": "27/02/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Non-Hodgkin Lymphoma.\n\nFrom clinical notes: Non-Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: abdominal lymphadenopathy with mesenteric and retroperitoneal nodes. Burkitt lymphoma confirmed on biopsy. High LDH levels. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"The report explicitly states the presence of abdominal lymphadenopathy, mesenteric and retroperitoneal nodes, confirmed Burkitt lymphoma on biopsy, and elevated LDH levels. These findings strongly indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"The report explicitly states the presence of abdominal lymphadenopathy, mesenteric and retroperitoneal nodes, confirmed Burkitt lymphoma on biopsy, and elevated LDH levels. These findings strongly indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"The report explicitly states the presence of abdominal lymphadenopathy, mesenteric and retroperitoneal nodes, confirmed Burkitt lymphoma on biopsy, and elevated LDH levels. These findings strongly indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"The report explicitly states the presence of abdominal lymphadenopathy, mesenteric and retroperitoneal nodes, confirmed Burkitt lymphoma on biopsy, and elevated LDH levels. These findings strongly indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\",",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly states the presence of abdominal lymphadenopathy, mesenteric and retroperitoneal nodes, confirmed Burkitt lymphoma on biopsy, and elevated LDH levels. These findings strongly indicate malignancy.",
      "findings": [
        "abdominal lymphadenopathy",
        "mesenteric and retroperitoneal nodes",
        "Burkitt lymphoma confirmed on biopsy",
        "high LDH levels"
      ],
      "fracture_mentioned": null,
      "idx": 3,
      "timestamp": "2026-01-10T18:24:08.432044"
    },
    {
      "sample_idx": 4,
      "input": "04/05/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 04/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"The report explicitly describes bone marrow infiltration with lymphoblasts (85%) and confirms the B-cell ALL immunophenotype, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"The report explicitly describes bone marrow infiltration with lymphoblasts (85%) and confirms the B-cell ALL immunophenotype, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"The report explicitly describes bone marrow infiltration with lymphoblasts (85%) and confirms the B-cell ALL immunophenotype, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"The report explicitly describes bone marrow infiltration with lymphoblasts (85%) and confirms the B-cell ALL immunophenotype, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"The report explicitly describes bone marrow infiltration with lymphoblasts (85%) and confirms",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly describes bone marrow infiltration with lymphoblasts (85%) and confirms the B-cell ALL immunophenotype, indicating malignancy.",
      "findings": [
        "bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells",
        "Immunophenotyping consistent with B-cell ALL"
      ],
      "fracture_mentioned": null,
      "idx": 4,
      "timestamp": "2026-01-10T18:24:08.432056"
    },
    {
      "sample_idx": 5,
      "input": "17/09/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 17/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly describes reactive lymphadenopathy, which is a non-cancerous condition. It also confirms that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes lymphadenopathy, which could be due to various causes, including infection or inflammation. The report explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes lymphadenopathy, which could be due to various causes, including infection or inflammation. The report explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes lymphadenopathy, which could be due to various causes, including infection or inflammation. The report explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes lymphadenopathy, which could be due to various causes, including infection or inflammation. The report explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes lymphadenopathy,",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly describes reactive lymphadenopathy, which is a non-cancerous condition. It also confirms that no malignancy was identified.",
      "findings": [
        "reactive lymphadenopathy",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 5,
      "timestamp": "2026-01-10T18:24:08.432068"
    },
    {
      "sample_idx": 6,
      "input": "11/07/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 11/07/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a large suprarenal mass with calcifications, MIBG avidity, elevated urinary catecholamines, and a Stage III diagnosis, all suggestive of neuroblastoma, a type of cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a large suprarenal mass with calcifications, MIBG avidity, elevated urinary catecholamines, and a Stage III diagnosis, all suggestive of neuroblastoma, a type of cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a large suprarenal mass with calcifications, MIBG avidity, elevated urinary catecholamines, and a Stage III diagnosis, all suggestive of neuroblastoma, a type of cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a large suprarenal mass with calcifications, MIBG avidity, elevated urinary catecholamines, and a Stage III diagnosis, all suggestive of neuroblastoma, a type of cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a large suprarenal mass with calcifications, MIBG avidity, elevated urinary catecholamines, and a Stage III diagnosis, all suggestive of neuroblastoma, a type of cancer.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "elevated urinary catecholamines",
        "Stage III disease"
      ],
      "fracture_mentioned": null,
      "idx": 6,
      "timestamp": "2026-01-10T18:24:08.432081"
    },
    {
      "sample_idx": 7,
      "input": "21/03/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified on the chest radiograph, lung fields, mediastinum, or heart. Reassurance was provided, indicating no concern for malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified on the chest radiograph, lung fields, mediastinum, or heart. Reassurance was provided, indicating no concern for malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified on the chest radiograph, lung fields, mediastinum, or heart. Reassurance was provided, indicating no concern for malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified on the chest radiograph, lung fields, mediastinum, or heart. Reassurance was provided, indicating no concern for malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        ",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that no malignancy was identified on the chest radiograph, lung fields, mediastinum, or heart. Reassurance was provided, indicating no concern for malignancy.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 7,
      "timestamp": "2026-01-10T18:24:08.432104"
    },
    {
      "sample_idx": 8,
      "input": "08/02/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 08/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\", \"No malignancy identified\"],\n        \"rationale\": \"The report states that the CBC is normal with age-appropriate values, no blast cells are present, and no malignancy is identified. Therefore, no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\", \"No malignancy identified\"],\n        \"rationale\": \"The report states that the CBC is normal with age-appropriate values, no blast cells are present, and no malignancy is identified. Therefore, no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\", \"No malignancy identified\"],\n        \"rationale\": \"The report states that the CBC is normal with age-appropriate values, no blast cells are present, and no malignancy is identified. Therefore, no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\", \"No malignancy identified\"],\n        \"rationale\": \"The report states that the CBC is normal with age-appropriate values, no blast cells are present, and no malignancy is identified. Therefore, no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"Platelets adequate\", \"Hem",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report states that the CBC is normal with age-appropriate values, no blast cells are present, and no malignancy is identified. Therefore, no malignancy is present.",
      "findings": [
        "Normal CBC with age-appropriate values",
        "No blast cells",
        "Platelets adequate",
        "Hemoglobin within normal limits",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 8,
      "timestamp": "2026-01-10T18:24:08.432118"
    },
    {
      "sample_idx": 9,
      "input": "25/04/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 25/04/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Stage II\", \"Favorable histology on biopsy\"],\n        \"rationale\": \"The report describes a large left renal mass with pseudocapsule, and the histology is favorable, indicating a Wilms tumor, a type of kidney cancer, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Stage II\", \"Favorable histology on biopsy\"],\n        \"rationale\": \"The report describes a large left renal mass with pseudocapsule, and the histology is favorable, indicating a Wilms tumor, a type of kidney cancer, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Stage II\", \"Favorable histology on biopsy\"],\n        \"rationale\": \"The report describes a large left renal mass with pseudocapsule, and the histology is favorable, indicating a Wilms tumor, a type of kidney cancer, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Stage II\", \"Favorable histology on biopsy\"],\n        \"rationale\": \"The report describes a large left renal mass with pseudocapsule, and the histology is favorable, indicating a Wilms tumor, a type of kidney cancer, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Stage II\", \"Favorable histology on biopsy\"],\n        \"rationale\": \"The report describes a large left renal mass with pseudocapsule, and the histology is favorable, indicating a Wil",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a large left renal mass with pseudocapsule, and the histology is favorable, indicating a Wilms tumor, a type of kidney cancer, confirming malignancy.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "Stage II",
        "Favorable histology on biopsy"
      ],
      "fracture_mentioned": null,
      "idx": 9,
      "timestamp": "2026-01-10T18:24:08.432131"
    },
    {
      "sample_idx": 10,
      "input": "26/12/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 26/12/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and confirms the diagnosis of Classical Hodgkin Lymphoma, nodular sclerosing type. This indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and confirms the diagnosis of Classical Hodgkin Lymphoma, nodular sclerosing type. This indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and confirms the diagnosis of Classical Hodgkin Lymphoma, nodular sclerosing type. This indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and confirms the diagnosis of Classical Hodgkin Lymphoma, nodular sclerosing type. This indicates malignancy.\"\n    }\n}\n",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and confirms the diagnosis of Classical Hodgkin Lymphoma, nodular sclerosing type. This indicates malignancy.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 10,
      "timestamp": "2026-01-10T18:24:08.432144"
    },
    {
      "sample_idx": 11,
      "input": "18/09/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 18/09/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, consistent with neuroblastoma. The stage III diagnosis further supports the presence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, consistent with neuroblastoma. The stage III diagnosis further supports the presence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, consistent with neuroblastoma. The stage III diagnosis further supports the presence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, consistent with neuroblastoma. The stage III diagnosis further supports the presence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, consistent with neuroblastoma. The stage III diagnosis further supports the presence of malignancy.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "elevated urinary catecholamines",
        "Stage III disease"
      ],
      "fracture_mentioned": null,
      "idx": 11,
      "timestamp": "2026-01-10T18:24:08.432157"
    },
    {
      "sample_idx": 12,
      "input": "15/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 15/12/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous hepatic mass with elevated AFP and a fetal histology subtype, indicating Hepatoblastoma. The PRETEXT stage II further supports the diagnosis of Hepatoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous hepatic mass with elevated AFP and a fetal histology subtype, indicating Hepatoblastoma. The PRETEXT stage II further supports the diagnosis of Hepatoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous hepatic mass with elevated AFP and a fetal histology subtype, indicating Hepatoblastoma. The PRETEXT stage II further supports the diagnosis of Hepatoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous hepatic mass with elevated AFP and a fetal histology subtype, indicating Hepatoblastoma. The PRETEXT stage II further supports the diagnosis of Hepatoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous hepatic mass with",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a large heterogeneous hepatic mass with elevated AFP and a fetal histology subtype, indicating Hepatoblastoma. The PRETEXT stage II further supports the diagnosis of Hepatoblastoma.",
      "findings": [
        "large heterogeneous hepatic mass",
        "elevated AFP",
        "Fetal histology subtype",
        "PRETEXT stage II"
      ],
      "fracture_mentioned": null,
      "idx": 12,
      "timestamp": "2026-01-10T18:24:08.432169"
    },
    {
      "sample_idx": 13,
      "input": "26/02/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Langerhans Cell Histiocytosis.\n\nFrom clinical notes: Langerhans Cell Histiocytosis. Paediatric oncology assessment.\n\nFindings: multiple lytic skull lesions with soft tissue component. CD1a and Langerin positive. Multisystem disease. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 26/02/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"multiple lytic skull lesions\", \"CD1a and Langerin positive\"],\n        \"rationale\": \"The report describes multiple lytic skull lesions with positive CD1a and Langerin staining, consistent with Langerhans Cell Histiocytosis, which is a type of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"Langerhans Cell Histiocytosis\", \"multisystem disease\"],\n        \"rationale\": \"The report explicitly mentions Langerhans Cell Histiocytosis, which is a known malignancy, and also indicates multisystem disease.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"Lytic skull lesions\", \"CD1a and Langerin positive\"],\n        \"rationale\": \"The report mentions lytic skull lesions and positive CD1a and Langerin staining, which are characteristic findings of Langerhans Cell Histiocytosis, a type of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"Langerhans Cell Histiocytosis\", \"multisystem disease\"],\n        \"rationale\": \"The report indicates Langerhans Cell Histiocytosis, a known malignancy, and also mentions multisystem disease, suggesting a systemic process.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"multiple lytic skull lesions\", \"CD1a and Langerin positive\"],\n        \"rationale\": \"The report explicitly mentions lytic skull lesions and positive CD1a and Langerin staining, which are characteristic findings of Langerhans Cell Histiocytosis, a type of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        ",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes multiple lytic skull lesions with positive CD1a and Langerin staining, consistent with Langerhans Cell Histiocytosis, which is a type of malignancy.",
      "findings": [
        "multiple lytic skull lesions",
        "CD1a and Langerin positive"
      ],
      "fracture_mentioned": null,
      "idx": 13,
      "timestamp": "2026-01-10T18:24:08.432180"
    },
    {
      "sample_idx": 14,
      "input": "08/09/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 08/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"no malignancy identified\"],\n        \"rationale\": \"The report identifies post-viral lymphocytosis, resolving atypical lymphocytes, and confirms EBV serology. No malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"no malignancy identified\"],\n        \"rationale\": \"The report identifies post-viral lymphocytosis, resolving atypical lymphocytes, and confirms EBV serology. No malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"no malignancy identified\"],\n        \"rationale\": \"The report identifies post-viral lymphocytosis, resolving atypical lymphocytes, and confirms EBV serology. No malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"no malignancy identified\"],\n        \"rationale\": \"The report identifies post-viral lymphocytosis, resolving atypical lymphocytes, and confirms EBV serology. No malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"no malignancy identified\"],\n        \"rationale\": \"The report identifies post-viral lymphocytosis, resolving",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report identifies post-viral lymphocytosis, resolving atypical lymphocytes, and confirms EBV serology. No malignancy is identified.",
      "findings": [
        "post-viral lymphocytosis",
        "atypical lymphocytes resolving",
        "monospot positive",
        "EBV serology confirms",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 14,
      "timestamp": "2026-01-10T18:24:08.432191"
    },
    {
      "sample_idx": 15,
      "input": "14/07/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Acute Myeloid Leukemia.\n\nFrom clinical notes: Acute Myeloid Leukemia. Paediatric oncology assessment.\n\nFindings: myeloblasts accounting for 70% of marrow cellularity. Cytogenetic analysis reveals t(8;21) translocation. Favorable risk category. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 14/07/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"The report identifies myeloblasts comprising 70% of the bone marrow cellularity, which is a hallmark of acute myeloid leukemia. The presence of t(8;21) translocation further confirms the diagnosis of AML.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"The report identifies myeloblasts comprising 70% of the bone marrow cellularity, which is a hallmark of acute myeloid leukemia. The presence of t(8;21) translocation further confirms the diagnosis of AML.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"The report identifies myeloblasts comprising 70% of the bone marrow cellularity, which is a hallmark of acute myeloid leukemia. The presence of t(8;21) translocation further confirms the diagnosis of AML.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"The report identifies myeloblasts comprising 70% of the bone marrow cellularity, which is a hallmark of acute myeloid leukemia. The presence of t(8;21) translocation further confirms the diagnosis of AML.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report identifies myeloblasts comprising 70% of the bone marrow cellularity, which is a hallmark of acute myeloid leukemia. The presence of t(8;21) translocation further confirms the diagnosis of AML.",
      "findings": [
        "myeloblasts accounting for 70% of marrow cellularity",
        "t(8;21) translocation"
      ],
      "fracture_mentioned": null,
      "idx": 15,
      "timestamp": "2026-01-10T18:24:08.432202"
    },
    {
      "sample_idx": 16,
      "input": "07/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 07/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"The report explicitly identifies an embryonal rhabdomyosarcoma with parameningeal mass and intracranial extension, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"The report explicitly states that the biopsy shows embryonal rhabdomyosarcoma, which is a type of cancer. The PAX-FOXO1 fusion status is also noted, which is relevant to the diagnosis and treatment planning.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\", \"parameningeal mass with intracranial extension\"],\n        \"rationale\": \"The report explicitly identifies embryonal rhabdomyosarcoma, a type of cancer, along with a parameningeal mass with intracranial extension, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"The report states that the biopsy shows embryonal rhabdomyosarcoma, which is a type of cancer. The PAX-FOXO1 fusion status is also noted, which is relevant to the diagnosis and treatment planning.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\", \"parameningeal mass with intracranial extension\"],\n        \"rationale\": \"The report explicitly identifies embryonal rhabdomyosar",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies an embryonal rhabdomyosarcoma with parameningeal mass and intracranial extension, indicating malignancy.",
      "findings": [
        "parameningeal mass with intracranial extension",
        "embryonal rhabdomyosarcoma on biopsy",
        "PAX-FOXO1 fusion negative"
      ],
      "fracture_mentioned": null,
      "idx": 16,
      "timestamp": "2026-01-10T18:24:08.432213"
    },
    {
      "sample_idx": 17,
      "input": "06/04/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 06/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report confirms that the chest radiograph shows no signs of malignancy, and there are no abnormal findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report confirms that the chest radiograph shows no signs of malignancy, and there are no abnormal findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report confirms that the chest radiograph shows no signs of malignancy, and there are no abnormal findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report confirms that the chest radiograph shows no signs of malignancy, and there are no abnormal findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report confirms that the chest radiograph shows no signs of malignancy, and there are no abnormal findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report confirms that the chest radiograph shows no signs of malignancy, and there are no abnormal findings.",
      "findings": [
        "normal chest radiograph",
        "clear lung fields",
        "no mediastinal mass",
        "heart size normal",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 17,
      "timestamp": "2026-01-10T18:24:08.432224"
    },
    {
      "sample_idx": 18,
      "input": "23/05/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Bone pain. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 23/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report explicitly mentions a posterior fossa mass, restricted diffusion, and a diagnosis of high-grade medulloblastoma, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report explicitly mentions a posterior fossa mass, restricted diffusion, and a diagnosis of high-grade medulloblastoma, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report explicitly mentions a posterior fossa mass, restricted diffusion, and a diagnosis of high-grade medulloblastoma, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report explicitly mentions a posterior fossa mass, restricted diffusion, and a diagnosis of high-grade medulloblastoma, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report explicitly mentions a posterior fossa mass, restricted diffusion, and a diagnosis of high-grade medulloblastoma, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly mentions a posterior fossa mass, restricted diffusion, and a diagnosis of high-grade medulloblastoma, confirming malignancy.",
      "findings": [
        "posterior fossa mass with enhancement and hydrocephalus",
        "Restricted diffusion",
        "High-grade medulloblastoma on histology"
      ],
      "fracture_mentioned": null,
      "idx": 18,
      "timestamp": "2026-01-10T18:24:08.432235"
    },
    {
      "sample_idx": 19,
      "input": "09/07/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 09/07/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are indicative of neuroblastoma. Stage III disease further supports the diagnosis of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are indicative of neuroblastoma. Stage III disease further supports the diagnosis of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are indicative of neuroblastoma. Stage III disease further supports the diagnosis of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are indicative of neuroblastoma. Stage III disease further supports the diagnosis of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are indicative of neuroblastoma. Stage III disease further supports the diagnosis of malignancy.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "elevated urinary catecholamines",
        "Stage III disease"
      ],
      "fracture_mentioned": null,
      "idx": 19,
      "timestamp": "2026-01-10T18:24:08.432248"
    },
    {
      "sample_idx": 20,
      "input": "18/08/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/08/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report describes a left renal mass with features suggestive of Wilms Tumor, confirmed by favorable histology and Stage II. The presence of a renal mass and the stage are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report describes a left renal mass with features suggestive of Wilms Tumor, confirmed by favorable histology and Stage II. The presence of a renal mass and the stage are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report describes a left renal mass with features suggestive of Wilms Tumor, confirmed by favorable histology and Stage II. The presence of a renal mass and the stage are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report describes a left renal mass with features suggestive of Wilms Tumor, confirmed by favorable histology and Stage II. The presence of a renal mass and the stage are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a left renal mass with features suggestive of Wilms Tumor, confirmed by favorable histology and Stage II. The presence of a renal mass and the stage are indicative of malignancy.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "no vascular invasion",
        "favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 20,
      "timestamp": "2026-01-10T18:24:08.432260"
    },
    {
      "sample_idx": 21,
      "input": "13/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 13/03/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the brain MRI is normal, and there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the brain MRI is normal, and there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the brain MRI is normal, and there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the brain MRI is normal, and there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the brain MRI is normal, and there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that the brain MRI is normal, and there is no evidence of malignancy.",
      "findings": [
        "normal brain MRI",
        "no mass lesion",
        "no abnormal enhancement",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 21,
      "timestamp": "2026-01-10T18:24:08.432270"
    },
    {
      "sample_idx": 22,
      "input": "18/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report explicitly mentions a left renal mass with characteristics suggestive of Wilms Tumor, along with the absence of vascular invasion and favorable histology. This confirms the presence of a malignant renal tumor (Wilms Tumor) and its stage.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report explicitly mentions a left renal mass with characteristics suggestive of Wilms Tumor, along with the absence of vascular invasion and favorable histology. This confirms the presence of a malignant renal tumor (Wilms Tumor) and its stage.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report explicitly mentions a left renal mass with characteristics suggestive of Wilms Tumor, along with the absence of vascular invasion and favorable histology. This confirms the presence of a malignant renal tumor (Wilms Tumor) and its stage.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report explicitly mentions a left renal mass with characteristics suggestive of Wilms Tumor, along with the absence of vascular invasion and favorable histology. This confirms the presence of a malignant renal tumor (Wilms Tumor) and its stage.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly mentions a left renal mass with characteristics suggestive of Wilms Tumor, along with the absence of vascular invasion and favorable histology. This confirms the presence of a malignant renal tumor (Wilms Tumor) and its stage.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "no vascular invasion",
        "favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 22,
      "timestamp": "2026-01-10T18:24:08.432283"
    },
    {
      "sample_idx": 23,
      "input": "02/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report indicates normal brain MRI with no evidence of mass lesion, abnormal enhancement, or malignancy. The patient was reassured of the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report indicates normal brain MRI with no evidence of mass lesion, abnormal enhancement, or malignancy. The patient was reassured of the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report indicates normal brain MRI with no evidence of mass lesion, abnormal enhancement, or malignancy. The patient was reassured of the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report indicates normal brain MRI with no evidence of mass lesion, abnormal enhancement, or malignancy. The patient was reassured of the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report indicates normal brain MRI with no evidence of mass lesion, abnormal enhancement, or malignancy. The patient was reassured of the absence of",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report indicates normal brain MRI with no evidence of mass lesion, abnormal enhancement, or malignancy. The patient was reassured of the absence of malignancy.",
      "findings": [
        "normal brain MRI",
        "no mass lesion",
        "no abnormal enhancement",
        "no malignancy identified",
        "reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 23,
      "timestamp": "2026-01-10T18:24:08.432295"
    },
    {
      "sample_idx": 24,
      "input": "16/05/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report describes a normal brain MRI with no evidence of malignancy. Reassurance was provided, indicating no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified and reassurance was provided.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report specifically states that no mass lesion, abnormal enhancement, or malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report indicates a normal brain MRI without any signs of malignancy or other abnormalities.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report confirms that no malignancy was identified and provides reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified, and reassurance was given.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes a normal brain MRI with no evidence of malignancy. Reassurance was provided, indicating no malignancy was identified.",
      "findings": [
        "normal brain MRI",
        "no mass lesion",
        "no abnormal enhancement",
        "no malignancy identified",
        "reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 24,
      "timestamp": "2026-01-10T18:24:08.432305"
    },
    {
      "sample_idx": 25,
      "input": "16/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis\", \"large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report explicitly describes findings consistent with Ewing Sarcoma, including bone destruction, soft tissue mass, periosteal reaction, and EWSR1 fusion positivity, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis\", \"large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report explicitly describes findings consistent with Ewing Sarcoma, including bone destruction, soft tissue mass, periosteal reaction, and EWSR1 fusion positivity, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis\", \"large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report explicitly describes findings consistent with Ewing Sarcoma, including bone destruction, soft tissue mass, periosteal reaction, and EWSR1 fusion positivity, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis\", \"large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report explicitly describes findings consistent with Ewing Sarcoma, including bone destruction, soft tissue mass, periosteal reaction, and EWSR1 fusion positivity, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malign",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly describes findings consistent with Ewing Sarcoma, including bone destruction, soft tissue mass, periosteal reaction, and EWSR1 fusion positivity, all of which are indicative of malignancy.",
      "findings": [
        "permeative bone destruction in left femoral diaphysis",
        "large soft tissue mass",
        "onion-skin periosteal reaction",
        "EWSR1 fusion positive"
      ],
      "fracture_mentioned": null,
      "idx": 25,
      "timestamp": "2026-01-10T18:24:08.432319"
    },
    {
      "sample_idx": 26,
      "input": "13/08/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Non-Hodgkin Lymphoma.\n\nFrom clinical notes: Non-Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: abdominal lymphadenopathy with mesenteric and retroperitoneal nodes. Burkitt lymphoma confirmed on biopsy. High LDH levels. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 13/08/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"The report explicitly mentions abdominal lymphadenopathy, confirmation of Burkitt lymphoma on biopsy, and elevated LDH levels, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"The report explicitly mentions abdominal lymphadenopathy, confirmation of Burkitt lymphoma on biopsy, and elevated LDH levels, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"The report explicitly mentions abdominal lymphadenopathy, confirmation of Burkitt lymphoma on biopsy, and elevated LDH levels, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"The report explicitly mentions abdominal lymphadenopathy, confirmation of Burkitt lymphoma on biopsy, and elevated LDH levels, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"The report explicitly mentions abdominal lymphadenopathy",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly mentions abdominal lymphadenopathy, confirmation of Burkitt lymphoma on biopsy, and elevated LDH levels, all of which are indicative of malignancy.",
      "findings": [
        "abdominal lymphadenopathy",
        "mesenteric and retroperitoneal nodes",
        "Burkitt lymphoma confirmed on biopsy",
        "high LDH levels"
      ],
      "fracture_mentioned": null,
      "idx": 26,
      "timestamp": "2026-01-10T18:24:08.432330"
    },
    {
      "sample_idx": 27,
      "input": "25/06/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 25/06/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report mentions a healing fracture with no pathological features and explicitly states that no malignancy was identified. This suggests a non-malignant finding.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report mentions a healing fracture with no pathological features and explicitly states that no malignancy was identified. This suggests a non-malignant finding.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report mentions a healing fracture with no pathological features and explicitly states that no malignancy was identified. This suggests a non-malignant finding.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report mentions a healing fracture with no pathological features and explicitly states that no malignancy was identified. This suggests a non-malignant finding.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report mentions a healing fracture with no pathological features and explicitly states that no malignancy was identified. This suggests a non-malignant finding.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"no pathological features\", \"no malignancy identified\"],\n",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report mentions a healing fracture with no pathological features and explicitly states that no malignancy was identified. This suggests a non-malignant finding.",
      "findings": [
        "healing fracture",
        "no pathological features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 27,
      "timestamp": "2026-01-10T18:24:08.432341"
    },
    {
      "sample_idx": 28,
      "input": "01/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 01/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"benign bone cyst - resolved\", \"no aggressive features\", \"normal bone density\", \"no recurrence on imaging\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there is no malignancy identified. The resolution of a benign bone cyst and normal bone density further support the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that there is no malignancy identified. The resolution of a benign bone cyst and normal bone density further support the absence of malignancy.",
      "findings": [
        "benign bone cyst - resolved",
        "no aggressive features",
        "normal bone density",
        "no recurrence on imaging",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 28,
      "timestamp": "2026-01-10T18:24:08.432352"
    },
    {
      "sample_idx": 29,
      "input": "04/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 04/12/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are all suggestive of neuroblastoma. The report also mentions Stage III disease, further supporting the diagnosis of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are all suggestive of neuroblastoma. The report also mentions Stage III disease, further supporting the diagnosis of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are all suggestive of neuroblastoma. The report also mentions Stage III disease, further supporting the diagnosis of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are all suggestive of neuroblastoma. The report also mentions Stage III disease, further supporting the diagnosis of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are all suggestive of neuroblastoma. The report also mentions Stage III disease, further supporting the diagnosis of malignancy.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "elevated urinary catecholamines",
        "Stage III disease"
      ],
      "fracture_mentioned": null,
      "idx": 29,
      "timestamp": "2026-01-10T18:24:08.432365"
    },
    {
      "sample_idx": 30,
      "input": "15/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 15/07/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"restricted diffusion\", \"high-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report describes a posterior fossa mass with enhancement and hydrocephalus, restricted diffusion, and confirms high-grade medulloblastoma, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"restricted diffusion\", \"high-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report describes a posterior fossa mass with enhancement and hydrocephalus, restricted diffusion, and confirms high-grade medulloblastoma, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"restricted diffusion\", \"high-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report describes a posterior fossa mass with enhancement and hydrocephalus, restricted diffusion, and confirms high-grade medulloblastoma, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"restricted diffusion\", \"high-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report describes a posterior fossa mass with enhancement and hydrocephalus, restricted diffusion, and confirms high-grade medulloblastoma, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"restricted diffusion\", \"high-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report describes a posterior fossa mass with enhancement and hydrocephalus, restricted diffusion, and confirms high-grade medulloblastoma, indicating malignancy.\"\n    }\n}\n```\n",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a posterior fossa mass with enhancement and hydrocephalus, restricted diffusion, and confirms high-grade medulloblastoma, indicating malignancy.",
      "findings": [
        "posterior fossa mass with enhancement and hydrocephalus",
        "restricted diffusion",
        "high-grade medulloblastoma on histology"
      ],
      "fracture_mentioned": null,
      "idx": 30,
      "timestamp": "2026-01-10T18:24:08.432377"
    },
    {
      "sample_idx": 31,
      "input": "02/04/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 02/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates a normal chest radiograph with no signs of malignancy. The findings are reassuring and suggest no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates a normal chest radiograph with no signs of malignancy. The findings are reassuring and suggest no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates a normal chest radiograph with no signs of malignancy. The findings are reassuring and suggest no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates a normal chest radiograph with no signs of malignancy. The findings are reassuring and suggest no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates a normal chest radiograph with no signs of malignancy. The findings are reassuring and suggest no malignancy is present.\"\n    }\n}\n```\n```json",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report indicates a normal chest radiograph with no signs of malignancy. The findings are reassuring and suggest no malignancy is present.",
      "findings": [
        "normal chest radiograph",
        "clear lung fields",
        "no mediastinal mass",
        "heart size normal",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 31,
      "timestamp": "2026-01-10T18:24:08.432387"
    },
    {
      "sample_idx": 32,
      "input": "04/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"The report describes a sacrococcygeal mass, elevated tumor markers, and the presence of yolk sac tumor elements, all indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"The report describes a sacrococcygeal mass, elevated tumor markers, and the presence of yolk sac tumor elements, all indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"The report describes a sacrococcygeal mass, elevated tumor markers, and the presence of yolk sac tumor elements, all indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"The report describes a sacrococcygeal mass, elevated tumor markers, and the presence of yolk sac tumor elements, all indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"elevated AFP and beta-h",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a sacrococcygeal mass, elevated tumor markers, and the presence of yolk sac tumor elements, all indicative of malignancy.",
      "findings": [
        "sacrococcygeal mass with mixed solid and cystic components",
        "elevated AFP and beta-hCG",
        "yolk sac tumor elements present"
      ],
      "fracture_mentioned": null,
      "idx": 32,
      "timestamp": "2026-01-10T18:24:08.432398"
    },
    {
      "sample_idx": 33,
      "input": "24/11/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report describes mediastinal lymphadenopathy, a bulky anterior mediastinal mass, and FDG-avid nodes, all of which are indicative of Hodgkin Lymphoma, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"Hodgkin Lymphoma\", \"nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions Hodgkin Lymphoma and specifies its nodular sclerosing type, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"FDG-avid nodes\", \"bulky anterior mediastinal mass\"],\n        \"rationale\": \"The report explicitly identifies FDG-avid nodes and a bulky anterior mediastinal mass, which are indicators of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\"],\n        \"rationale\": \"The report mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, and FDG-avid nodes, which are all indicators of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"Hodgkin Lymphoma\", \"nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions Hodgkin Lymphoma and specifies its nodular sclerosing type, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes mediastinal lymphadenopathy, a bulky anterior mediastinal mass, and FDG-avid nodes, all of which are indicative of Hodgkin Lymphoma, confirming malignancy.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 33,
      "timestamp": "2026-01-10T18:24:08.432410"
    },
    {
      "sample_idx": 34,
      "input": "07/03/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 07/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no abnormal findings, no blast cells, and no malignancy. The CBC is normal. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no abnormal findings, no blast cells, and no malignancy. The CBC is normal. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no abnormal findings, no blast cells, and no malignancy. The CBC is normal. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no abnormal findings, no blast cells, and no malignancy. The CBC is normal. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hem",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that there are no abnormal findings, no blast cells, and no malignancy. The CBC is normal. Therefore, there is no evidence of malignancy.",
      "findings": [
        "normal CBC with age-appropriate values",
        "no blast cells",
        "platelets adequate",
        "hemoglobin within normal limits",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 34,
      "timestamp": "2026-01-10T18:24:08.432422"
    },
    {
      "sample_idx": 35,
      "input": "04/10/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"benign soft tissue mass - lipoma\", \"No malignancy identified\", \"Reassurance provided\"],\n        \"rationale\": \"The report confirms the presence of a benign lipoma and explicitly states that no malignancy was identified. The reassurance provided further supports the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"benign soft tissue mass - lipoma\", \"No malignancy identified\", \"Reassurance provided\"],\n        \"rationale\": \"The report confirms the presence of a benign lipoma and explicitly states that no malignancy was identified. The reassurance provided further supports the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"benign soft tissue mass - lipoma\", \"No malignancy identified\", \"Reassurance provided\"],\n        \"rationale\": \"The report confirms the presence of a benign lipoma and explicitly states that no malignancy was identified. The reassurance provided further supports the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"benign soft tissue mass - lipoma\", \"No malignancy identified\", \"Reassurance provided\"],\n        \"rationale\": \"The report confirms the presence of a benign lipoma and explicitly states that no malignancy was identified. The reassurance provided further supports the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"benign soft tissue mass - lipoma\", \"No malignancy identified\", \"Reassurance provided\"],\n        \"rationale\": \"The report confirms the presence of a benign lipoma and explicitly states that no malignancy was identified. The reassurance provided further supports the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report confirms the presence of a benign lipoma and explicitly states that no malignancy was identified. The reassurance provided further supports the absence of malignancy.",
      "findings": [
        "benign soft tissue mass - lipoma",
        "No malignancy identified",
        "Reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 35,
      "timestamp": "2026-01-10T18:24:08.432432"
    },
    {
      "sample_idx": 36,
      "input": "04/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph, lung fields, mediastinum, heart size, and bone marrow biopsy show no malignancy. The patient was reassured.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no abnormal findings\", \"normal bone marrow\", \"no evidence of malignancy\"],\n        \"rationale\": \"The report indicates that there are no abnormal findings in the bone marrow and no evidence of malignancy. The bone marrow is normal.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"normal bone marrow\"],\n        \"rationale\": \"The report explicitly states that there is no evidence of malignancy and the bone marrow is normal.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"normal bone marrow\"],\n        \"rationale\": \"The report explicitly states that there is no evidence of malignancy and the bone marrow is normal.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"normal bone marrow\"],\n        \"rationale\": \"The report explicitly states that there is no evidence of malignancy and the bone marrow is normal.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"normal bone marrow\"],\n        \"rationale\": \"The report explicitly states that there is no evidence of malignancy and the bone marrow is normal.\"\n    }\n",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that the chest radiograph, lung fields, mediastinum, heart size, and bone marrow biopsy show no malignancy. The patient was reassured.",
      "findings": [
        "normal chest radiograph",
        "clear lung fields",
        "no mediastinal mass",
        "heart size normal",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 36,
      "timestamp": "2026-01-10T18:24:08.432443"
    },
    {
      "sample_idx": 37,
      "input": "02/04/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 02/04/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur\", \"soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur, a soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase. These findings are consistent with osteosarcoma, a type of bone cancer, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur\", \"soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur, a soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase. These findings are consistent with osteosarcoma, a type of bone cancer, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur\", \"soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur, a soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase. These findings are consistent with osteosarcoma, a type of bone cancer, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur\", \"soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur, a soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase. These findings are consistent with osteosarcoma, a type of bone cancer, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a destructive lesion in the distal femur, a soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase. These findings are consistent with osteosarcoma, a type of bone cancer, indicating malignancy.",
      "findings": [
        "destructive lesion in distal femur",
        "soft tissue component",
        "sunburst periosteal reaction",
        "elevated alkaline phosphatase"
      ],
      "fracture_mentioned": null,
      "idx": 37,
      "timestamp": "2026-01-10T18:24:08.432456"
    },
    {
      "sample_idx": 38,
      "input": "05/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 05/03/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with soft tissue involvement and a sunburst periosteal reaction, which are concerning for osteosarcoma. Elevated alkaline phosphatase further supports the possibility of bone tumor. The report also mentions a need for MDT discussion and treatment planning, which is consistent with a suspected malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with soft tissue involvement and a sunburst periosteal reaction, which are concerning for osteosarcoma. Elevated alkaline phosphatase further supports the possibility of bone tumor. The report also mentions a need for MDT discussion and treatment planning, which is consistent with a suspected malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with soft tissue involvement and a sunburst periosteal reaction, which are concerning for osteosarcoma. Elevated alkaline phosphatase further supports the possibility of bone tumor. The report also mentions a need for MDT discussion and treatment planning, which is consistent with a suspected malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with soft tissue involvement and a sunburst periosteal reaction, which are concerning",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a destructive lesion in the distal femur with soft tissue involvement and a sunburst periosteal reaction, which are concerning for osteosarcoma. Elevated alkaline phosphatase further supports the possibility of bone tumor. The report also mentions a need for MDT discussion and treatment planning, which is consistent with a suspected malignancy.",
      "findings": [
        "destructive lesion in distal femur with soft tissue component",
        "sunburst periosteal reaction",
        "elevated alkaline phosphatase"
      ],
      "fracture_mentioned": null,
      "idx": 38,
      "timestamp": "2026-01-10T18:24:08.432471"
    },
    {
      "sample_idx": 39,
      "input": "01/11/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 01/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that post-viral lymphocytosis is present, and atypical lymphocytes are resolving, with confirmation of EBV serology. The report also explicitly states that no malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphoblasts 85% of marrow\", \"B-cell ALL immunophenotype\", \"bone marrow infiltration\"],\n        \"rationale\": \"The report explicitly identifies bone marrow infiltration with lymphoblasts and immunophenotyping consistent with acute lymphoblastic leukemia, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphoblasts 85% of marrow\", \"B-cell ALL immunophenotype\", \"bone marrow infiltration\"],\n        \"rationale\": \"The report explicitly identifies bone marrow infiltration with lymphoblasts and immunophenotyping consistent with acute lymphoblastic leukemia, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphoblasts 85% of marrow\", \"B-cell ALL immunophenotype\", \"bone marrow infiltration\"],\n        \"rationale\": \"The report explicitly identifies bone marrow infiltration with lymphoblasts and immunophenotyping consistent with acute lymphoblastic leukemia, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    ",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that post-viral lymphocytosis is present, and atypical lymphocytes are resolving, with confirmation of EBV serology. The report also explicitly states that no malignancy is identified.",
      "findings": [
        "post-viral lymphocytosis",
        "atypical lymphocytes resolving",
        "monospot positive",
        "EBV serology confirms",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 39,
      "timestamp": "2026-01-10T18:24:08.432483"
    },
    {
      "sample_idx": 40,
      "input": "26/04/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 26/04/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report describes a renal mass with features suggestive of Wilms tumor, including a pseudocapsule and favorable histology. The stage is also specified as II. These findings indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report describes a renal mass with features suggestive of Wilms tumor, including a pseudocapsule and favorable histology. The stage is also specified as II. These findings indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report describes a renal mass with features suggestive of Wilms tumor, including a pseudocapsule and favorable histology. The stage is also specified as II. These findings indicate malignancy.\"\n    }\n}\n```\n```json\n{\n",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a renal mass with features suggestive of Wilms tumor, including a pseudocapsule and favorable histology. The stage is also specified as II. These findings indicate malignancy.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "no vascular invasion",
        "favorable histology on biopsy",
        "stage II"
      ],
      "fracture_mentioned": null,
      "idx": 40,
      "timestamp": "2026-01-10T18:24:08.432494"
    },
    {
      "sample_idx": 41,
      "input": "18/11/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report describes mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and a diagnosis of Classical Hodgkin Lymphoma, nodular sclerosing type. These findings are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"Hodgkin Lymphoma\", \"nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions Hodgkin Lymphoma, nodular sclerosing type, which is a type of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"FDG-avid nodes\"],\n        \"rationale\": \"The report describes FDG-avid nodes, which are a hallmark of malignancy, particularly in the context of Hodgkin Lymphoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bulky anterior mediastinal mass\"],\n        \"rationale\": \"The report describes a bulky anterior mediastinal mass, which is a significant finding suggestive of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\"],\n        \"rationale\": \"The report describes mediastinal lymphadenopathy, which is a common finding in malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"Hodgkin Lymphoma\"],\n        \"rationale\": \"The report mentions Hodgkin Lymphoma, which is a type of",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and a diagnosis of Classical Hodgkin Lymphoma, nodular sclerosing type. These findings are indicative of malignancy.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 41,
      "timestamp": "2026-01-10T18:24:08.432506"
    },
    {
      "sample_idx": 42,
      "input": "20/04/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 20/04/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"The report describes atypical lymphocytes resolving, a positive Monospot test, and confirmed EBV serology. While atypical lymphocytes can sometimes be associated with malignancy, the report explicitly states that no malignancy was identified and that the findings are consistent with a viral infection.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified and that reassurance was provided. This indicates the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"The report describes atypical lymphocytes resolving, a positive Monospot test, and confirmed EBV serology. While atypical lymphocytes can sometimes be associated with malignancy, the report explicitly states that no malignancy was identified and that the findings are consistent with a viral infection.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified and that reassurance was provided. This indicates the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified and that reassurance was provided. This indicates the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    ",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes atypical lymphocytes resolving, a positive Monospot test, and confirmed EBV serology. While atypical lymphocytes can sometimes be associated with malignancy, the report explicitly states that no malignancy was identified and that the findings are consistent with a viral infection.",
      "findings": [
        "Atypical lymphocytes resolving",
        "Monospot positive",
        "EBV serology confirms"
      ],
      "fracture_mentioned": null,
      "idx": 42,
      "timestamp": "2026-01-10T18:24:08.432519"
    },
    {
      "sample_idx": 43,
      "input": "20/01/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 20/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates a normal brain MRI with no evidence of mass lesion, abnormal enhancement, or malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no findings of malignancy\", \"normal appearance\"],\n        \"rationale\": \"The report states that no findings of malignancy were present, and the appearance is normal.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"normal findings\"],\n        \"rationale\": \"The report explicitly states there is no evidence of malignancy and that the findings are normal.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no signs of malignancy\", \"normal appearance\"],\n        \"rationale\": \"The report mentions no signs of malignancy and a normal appearance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"normal\"],\n        \"rationale\": \"The report states there is no evidence of malignancy and the findings are normal.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"normal\"],\n        \"rationale\": \"The report indicates no evidence of malignancy and normal findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"normal\"],\n        \"rationale\": \"The",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report indicates a normal brain MRI with no evidence of mass lesion, abnormal enhancement, or malignancy.",
      "findings": [
        "normal brain MRI",
        "no mass lesion",
        "no abnormal enhancement",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 43,
      "timestamp": "2026-01-10T18:24:08.432528"
    },
    {
      "sample_idx": 44,
      "input": "22/11/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 22/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis with large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report describes bone destruction, a soft tissue mass, and EWSR1 fusion positivity, all of which are indicative of Ewing Sarcoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis with large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report describes bone destruction, a soft tissue mass, and EWSR1 fusion positivity, all of which are indicative of Ewing Sarcoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis with large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report describes bone destruction, a soft tissue mass, and EWSR1 fusion positivity, all of which are indicative of Ewing Sarcoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis with large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report describes bone destruction, a soft tissue mass, and EWSR1 fusion positivity, all of which are indicative of Ewing Sarcoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis with large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes bone destruction, a soft tissue mass, and EWSR1 fusion positivity, all of which are indicative of Ewing Sarcoma.",
      "findings": [
        "permeative bone destruction in left femoral diaphysis with large soft tissue mass",
        "onion-skin periosteal reaction",
        "EWSR1 fusion positive"
      ],
      "fracture_mentioned": null,
      "idx": 44,
      "timestamp": "2026-01-10T18:24:08.432539"
    },
    {
      "sample_idx": 45,
      "input": "06/05/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 06/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes a normal brain MRI without any abnormalities, mass lesions, or evidence of malignancy. Reassurance was provided.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no abnormal findings\", \"no evidence of malignancy\"],\n        \"rationale\": \"The report indicates no abnormal findings and no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal appearance\", \"no evidence of malignancy\"],\n        \"rationale\": \"The report describes a normal appearance and no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal\", \"no evidence of malignancy\"],\n        \"rationale\": \"The report indicates a normal finding and no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal\", \"no evidence of malignancy\"],\n        \"rationale\": \"The report indicates a normal finding and no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal\", \"no evidence of malignancy\"],\n        \"rationale\": \"The report indicates a normal finding and no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal\", \"no evidence of malignancy\"],\n        \"rationale\": \"The report indicates a normal finding and no evidence",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes a normal brain MRI without any abnormalities, mass lesions, or evidence of malignancy. Reassurance was provided.",
      "findings": [
        "normal brain MRI",
        "no mass lesion",
        "no abnormal enhancement",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 45,
      "timestamp": "2026-01-10T18:24:08.432550"
    },
    {
      "sample_idx": 46,
      "input": "24/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Physiological splenomegaly for age\", \"No focal lesions\", \"Normal echo texture\", \"Benign finding\", \"No malignancy identified\"],\n        \"rationale\": \"The report states that the splenomegaly is physiological for age and that no focal lesions, normal echo texture, benign finding or malignancy are identified. Therefore, the finding does not indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Physiological splenomegaly for age\", \"No focal lesions\", \"Normal echo texture\", \"Benign finding\", \"No malignancy identified\"],\n        \"rationale\": \"The report states that the splenomegaly is physiological for age and that no focal lesions, normal echo texture, benign finding or malignancy are identified. Therefore, the finding does not indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Physiological splenomegaly for age\", \"No focal lesions\", \"Normal echo texture\", \"Benign finding\", \"No malignancy identified\"],\n        \"rationale\": \"The report states that the splenomegaly is physiological for age and that no focal lesions, normal echo texture, benign finding or malignancy are identified. Therefore, the finding does not indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Physiological splenomegaly for age\", \"No focal lesions\", \"Normal echo texture\", \"Benign finding\", \"No malignancy identified\"],\n        \"rationale\": \"The report states that the splenomegaly is physiological for age and that no focal lesions, normal echo texture, benign finding or malignancy are identified. Therefore, the finding does not indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Physiological splenomegaly for age\",",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report states that the splenomegaly is physiological for age and that no focal lesions, normal echo texture, benign finding or malignancy are identified. Therefore, the finding does not indicate malignancy.",
      "findings": [
        "Physiological splenomegaly for age",
        "No focal lesions",
        "Normal echo texture",
        "Benign finding",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 46,
      "timestamp": "2026-01-10T18:24:08.432562"
    },
    {
      "sample_idx": 47,
      "input": "01/02/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 01/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign finding. There are no atypical features or malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign finding. There are no atypical features or malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign finding. There are no atypical features or malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign finding. There are no atypical features or malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign finding. There are no atypical features or malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes reactive lymphadenopathy, which is a benign finding. There are no atypical features or malignancy identified.",
      "findings": [
        "reactive lymphadenopathy",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 47,
      "timestamp": "2026-01-10T18:24:08.432572"
    },
    {
      "sample_idx": 48,
      "input": "03/10/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 03/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur\", \"soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with a soft tissue component and sunburst periosteal reaction, strongly suggestive of osteosarcoma. Elevated alkaline phosphatase also supports this diagnosis. The clinical context of suspected osteosarcoma further strengthens this conclusion.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur\", \"soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with a soft tissue component and sunburst periosteal reaction, strongly suggestive of osteosarcoma. Elevated alkaline phosphatase also supports this diagnosis. The clinical context of suspected osteosarcoma further strengthens this conclusion.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur\", \"soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with a soft tissue component and sunburst periosteal reaction, strongly suggestive of osteosarcoma. Elevated alkaline phosphatase also supports this diagnosis. The clinical context of suspected osteosarcoma further strengthens this conclusion.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur\", \"soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with a soft tissue component and sunburst periosteal reaction, strongly suggestive of osteosarcoma. Elevated alkaline phosphatase also supports this diagnosis. The clinical context of suspected osteosarcoma further strengthens this conclusion.\"\n    }\n}\n```\n```json",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a destructive lesion in the distal femur with a soft tissue component and sunburst periosteal reaction, strongly suggestive of osteosarcoma. Elevated alkaline phosphatase also supports this diagnosis. The clinical context of suspected osteosarcoma further strengthens this conclusion.",
      "findings": [
        "destructive lesion in distal femur",
        "soft tissue component",
        "sunburst periosteal reaction",
        "elevated alkaline phosphatase"
      ],
      "fracture_mentioned": null,
      "idx": 48,
      "timestamp": "2026-01-10T18:24:08.432586"
    },
    {
      "sample_idx": 49,
      "input": "05/08/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 05/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign finding. It explicitly states that no atypical features or malignancy are identified. Therefore, no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphoblasts 85% of marrow\", \"B-cell ALL immunophenotype\", \"bone marrow infiltration\"],\n        \"rationale\": \"The report explicitly identifies bone marrow infiltration with lymphoblasts and immunophenotyping consistent with acute lymphoblastic leukemia, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"lymphoblasts 85% of marrow\", \"B-cell ALL immunophenotype\", \"bone marrow infiltration\"],\n        \"rationale\": \"The report explicitly identifies bone marrow infiltration with lymphoblasts and immunophenotyping consistent with acute lymphoblastic leukemia, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign finding. It explicitly states that no atypical features or malignancy are identified. Therefore, no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes reactive lymphadenopathy, which is a benign finding. It explicitly states that no atypical features or malignancy are identified. Therefore, no malignancy is present.",
      "findings": [
        "reactive lymphadenopathy",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 49,
      "timestamp": "2026-01-10T18:24:08.432597"
    },
    {
      "sample_idx": 50,
      "input": "02/05/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report describes a normal chest radiograph, clear lung fields, no mediastinal mass, normal heart size, and explicitly states that no malignancy was identified. Reassurance was provided. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report describes a normal chest radiograph, clear lung fields, no mediastinal mass, normal heart size, and explicitly states that no malignancy was identified. Reassurance was provided. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report describes a normal chest radiograph, clear lung fields, no mediastinal mass, normal heart size, and explicitly states that no malignancy was identified. Reassurance was provided. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report describes a normal chest radiograph, clear lung fields, no mediastinal mass, normal heart size, and explicitly states that no malignancy was identified. Reassurance was provided. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes a normal chest radiograph, clear lung fields, no mediastinal mass, normal heart size, and explicitly states that no malignancy was identified. Reassurance was provided. Therefore, there is no evidence of malignancy.",
      "findings": [
        "normal chest radiograph",
        "clear lung fields",
        "no mediastinal mass",
        "heart size normal",
        "no malignancy identified",
        "reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 50,
      "timestamp": "2026-01-10T18:24:08.432609"
    },
    {
      "sample_idx": 51,
      "input": "26/07/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 26/07/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lipoma\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes a lipoma, and explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lipoma\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes a lipoma, and explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lipoma\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes a lipoma, and explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lipoma\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes a lipoma, and explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lipoma\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes a lipoma, and explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lipoma\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes a lipoma, and explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lipoma\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes a lipoma, and explicitly",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes a lipoma, and explicitly states that no malignancy was identified.",
      "findings": [
        "lipoma",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 51,
      "timestamp": "2026-01-10T18:24:08.432617"
    },
    {
      "sample_idx": 52,
      "input": "25/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Bone pain. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 25/03/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report describes a left renal mass with characteristics suggestive of Wilms Tumor, including a pseudocapsule, absence of vascular invasion, and favorable histology. The stage II classification further supports the diagnosis of Wilms Tumor, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report describes a left renal mass with characteristics suggestive of Wilms Tumor, including a pseudocapsule, absence of vascular invasion, and favorable histology. The stage II classification further supports the diagnosis of Wilms Tumor, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report describes a left renal mass with characteristics suggestive of Wilms Tumor, including a pseudocapsule, absence of vascular invasion, and favorable histology. The stage II classification further supports the diagnosis of Wilms Tumor, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report describes a left renal mass with characteristics suggestive of Wilms Tumor, including a pseudocapsule, absence of vascular invasion, and favorable histology. The stage II classification further supports the diagnosis of Wilms Tumor, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malign",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a left renal mass with characteristics suggestive of Wilms Tumor, including a pseudocapsule, absence of vascular invasion, and favorable histology. The stage II classification further supports the diagnosis of Wilms Tumor, indicating malignancy.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "no vascular invasion",
        "favorable histology on biopsy",
        "stage II"
      ],
      "fracture_mentioned": null,
      "idx": 52,
      "timestamp": "2026-01-10T18:24:08.432631"
    },
    {
      "sample_idx": 53,
      "input": "05/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 05/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates reactive lymphadenopathy, which is a non-cancerous condition. The absence of atypical features and the explicit statement of no malignancy confirm that the findings do not represent malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates reactive lymphadenopathy, which is a non-cancerous condition. The absence of atypical features and the explicit statement of no malignancy confirm that the findings do not represent malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates reactive lymphadenopathy, which is a non-cancerous condition. The absence of atypical features and the explicit statement of no malignancy confirm that the findings do not represent malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates reactive lymphadenopathy, which is a non-cancerous condition. The absence of atypical features and the explicit statement of no malignancy confirm that the findings do not represent malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates reactive lymphadenopathy, which is a non-cancerous condition. The absence of atypical features and the explicit statement of no malignancy confirm that the findings do not represent malignancy.\"",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report indicates reactive lymphadenopathy, which is a non-cancerous condition. The absence of atypical features and the explicit statement of no malignancy confirm that the findings do not represent malignancy.",
      "findings": [
        "reactive lymphadenopathy",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 53,
      "timestamp": "2026-01-10T18:24:08.432642"
    },
    {
      "sample_idx": 54,
      "input": "23/03/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 23/03/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous hepatic mass, elevated AFP, a specific histology subtype, and a stage indicating a malignancy (Hepatoblastoma). The report explicitly mentions Hepatoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous hepatic mass, elevated AFP, a specific histology subtype, and a stage indicating a malignancy (Hepatoblastoma). The report explicitly mentions Hepatoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous hepatic mass, elevated AFP, a specific histology subtype, and a stage indicating a malignancy (Hepatoblastoma). The report explicitly mentions Hepatoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous hepatic mass, elevated AFP, a specific histology subtype, and a stage indicating a malignancy (Hepatoblastoma). The report explicitly mentions Hepatoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a large heterogeneous hepatic mass, elevated AFP, a specific histology subtype, and a stage indicating a malignancy (Hepatoblastoma). The report explicitly mentions Hepatoblastoma.",
      "findings": [
        "large heterogeneous hepatic mass",
        "elevated AFP",
        "Fetal histology subtype",
        "PRETEXT stage II"
      ],
      "fracture_mentioned": null,
      "idx": 54,
      "timestamp": "2026-01-10T18:24:08.432653"
    },
    {
      "sample_idx": 55,
      "input": "31/08/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 31/08/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the chest radiograph is normal and no malignancy is identified. No abnormal findings indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the chest radiograph is normal and no malignancy is identified. No abnormal findings indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the chest radiograph is normal and no malignancy is identified. No abnormal findings indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the chest radiograph is normal and no malignancy is identified. No abnormal findings indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the chest radiograph is normal and no malignancy is identified. No abnormal findings indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report states that the chest radiograph is normal and no malignancy is identified. No abnormal findings indicating malignancy.",
      "findings": [
        "normal chest radiograph",
        "clear lung fields",
        "no mediastinal mass",
        "heart size normal",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 55,
      "timestamp": "2026-01-10T18:24:08.432664"
    },
    {
      "sample_idx": 56,
      "input": "26/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 26/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign finding. The report explicitly states that no atypical features or malignancy were identified. Therefore, malignancy is not present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign finding. The report explicitly states that no atypical features or malignancy were identified. Therefore, malignancy is not present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign finding. The report explicitly states that no atypical features or malignancy were identified. Therefore, malignancy is not present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign finding. The report explicitly states that no atypical features or malignancy were identified. Therefore, malignancy is not present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign finding. The report explicitly states that no atypical features or malignancy were identified. Therefore, malignancy is not present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\":",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes reactive lymphadenopathy, which is a benign finding. The report explicitly states that no atypical features or malignancy were identified. Therefore, malignancy is not present.",
      "findings": [
        "reactive lymphadenopathy",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 56,
      "timestamp": "2026-01-10T18:24:08.432675"
    },
    {
      "sample_idx": 57,
      "input": "24/11/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"The report explicitly mentions a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG levels, and the presence of yolk sac tumor elements. These findings are highly suggestive of a Germ Cell Tumor, a type of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"The report explicitly mentions a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG levels, and the presence of yolk sac tumor elements. These findings are highly suggestive of a Germ Cell Tumor, a type of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"The report explicitly mentions a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG levels, and the presence of yolk sac tumor elements. These findings are highly suggestive of a Germ Cell Tumor, a type of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"The report explicitly mentions a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG levels",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly mentions a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG levels, and the presence of yolk sac tumor elements. These findings are highly suggestive of a Germ Cell Tumor, a type of malignancy.",
      "findings": [
        "sacrococcygeal mass with mixed solid and cystic components",
        "elevated AFP and beta-hCG",
        "yolk sac tumor elements present"
      ],
      "fracture_mentioned": null,
      "idx": 57,
      "timestamp": "2026-01-10T18:24:08.432687"
    },
    {
      "sample_idx": 58,
      "input": "01/01/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 01/01/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass\", \"mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements, all of which are indicative of a germ cell tumor, specifically a Yolk Sac Tumor. These findings strongly suggest malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass\", \"mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements, all of which are indicative of a germ cell tumor, specifically a Yolk Sac Tumor. These findings strongly suggest malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass\", \"mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements, all of which are indicative of a germ cell tumor, specifically a Yolk Sac Tumor. These findings strongly suggest malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass\", \"mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"The report describes a sac",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements, all of which are indicative of a germ cell tumor, specifically a Yolk Sac Tumor. These findings strongly suggest malignancy.",
      "findings": [
        "sacrococcygeal mass",
        "mixed solid and cystic components",
        "elevated AFP and beta-hCG",
        "yolk sac tumor elements present"
      ],
      "fracture_mentioned": null,
      "idx": 58,
      "timestamp": "2026-01-10T18:24:08.432700"
    },
    {
      "sample_idx": 59,
      "input": "16/06/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/06/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\", \"parameningeal mass with intracranial extension\"],\n        \"rationale\": \"The report explicitly states 'embryonal rhabdomyosarcoma' and describes a 'parameningeal mass with intracranial extension', indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\"],\n        \"rationale\": \"The report states 'embryonal rhabdomyosarcoma', indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\"],\n        \"rationale\": \"The report explicitly mentions 'parameningeal mass with intracranial extension', which indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\"],\n        \"rationale\": \"The report explicitly identifies 'embryonal rhabdomyosarcoma', which is a type of cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\"],\n        \"rationale\": \"The report indicates the presence of 'embryonal rhabdomyosarcoma', which is a malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\"],\n        \"rationale\": \"The report explicitly mentions 'embryonal rhabdomyosarcoma', which is a cancerous tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malign",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly states 'embryonal rhabdomyosarcoma' and describes a 'parameningeal mass with intracranial extension', indicating malignancy.",
      "findings": [
        "embryonal rhabdomyosarcoma",
        "parameningeal mass with intracranial extension"
      ],
      "fracture_mentioned": null,
      "idx": 59,
      "timestamp": "2026-01-10T18:24:08.432710"
    },
    {
      "sample_idx": 60,
      "input": "08/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 08/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no mass lesion, abnormal enhancement, or malignancy were identified on the CT scan, and the brain MRI was normal. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no mass lesion, abnormal enhancement, or malignancy were identified on the CT scan, and the brain MRI was normal. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no mass lesion, abnormal enhancement, or malignancy were identified on the CT scan, and the brain MRI was normal. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no mass lesion, abnormal enhancement, or malignancy were identified on the CT scan, and the brain MRI was normal. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no mass lesion, abnormal enhancement, or malignancy were identified on the CT scan, and the brain MRI was normal. No evidence of malignancy.\"\n    }\n}",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that no mass lesion, abnormal enhancement, or malignancy were identified on the CT scan, and the brain MRI was normal. No evidence of malignancy.",
      "findings": [
        "normal brain MRI",
        "no mass lesion",
        "no abnormal enhancement",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 60,
      "timestamp": "2026-01-10T18:24:08.432721"
    },
    {
      "sample_idx": 61,
      "input": "09/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 09/07/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"No malignancy identified\"],\n        \"rationale\": \"The report describes post-viral lymphocytosis and atypical lymphocytes resolving, confirmed by EBV serology. No malignancy is identified, and reassurance is provided.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"No malignancy identified\"],\n        \"rationale\": \"The report describes post-viral lymphocytosis and atypical lymphocytes resolving, confirmed by EBV serology. No malignancy is identified, and reassurance is provided.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"No malignancy identified\"],\n        \"rationale\": \"The report describes post-viral lymphocytosis and atypical lymphocytes resolving, confirmed by EBV serology. No malignancy is identified, and reassurance is provided.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"No malignancy identified\"],\n        \"rationale\": \"The report describes post-viral lymphocytosis and atypical lymphocytes resolving, confirmed by EBV serology. No malignancy is identified, and reassurance is provided.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\",",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes post-viral lymphocytosis and atypical lymphocytes resolving, confirmed by EBV serology. No malignancy is identified, and reassurance is provided.",
      "findings": [
        "post-viral lymphocytosis",
        "atypical lymphocytes resolving",
        "monospot positive",
        "EBV serology confirms",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 61,
      "timestamp": "2026-01-10T18:24:08.432732"
    },
    {
      "sample_idx": 62,
      "input": "08/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 08/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that reactive lymphadenopathy was found, with no atypical features and no malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy, which is not indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy, which is not indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy, which is not indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy, which is not indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy, which is not indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy, which is not indicative of malignancy.\"\n",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that reactive lymphadenopathy was found, with no atypical features and no malignancy identified.",
      "findings": [
        "reactive lymphadenopathy",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 62,
      "timestamp": "2026-01-10T18:24:08.432742"
    },
    {
      "sample_idx": 63,
      "input": "04/12/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 04/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"blood counts normalized\", \"no organomegaly\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates a resolved febrile illness and normalized blood counts, suggesting the patient is in good condition. It explicitly states that no malignancy was identified, ruling out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"blood counts normalized\", \"no organomegaly\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates a resolved febrile illness and normalized blood counts, suggesting the patient is in good condition. It explicitly states that no malignancy was identified, ruling out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"blood counts normalized\", \"no organomegaly\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates a resolved febrile illness and normalized blood counts, suggesting the patient is in good condition. It explicitly states that no malignancy was identified, ruling out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"blood counts normalized\", \"no organomegaly\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates a resolved febrile illness and normalized blood counts, suggesting the patient is in good condition. It explicitly states that no malignancy was identified, ruling out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"blood counts normalized\", \"no organomegaly\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates a resolved febrile illness and normalized blood counts, suggesting the patient is in good condition. It explicitly states",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report indicates a resolved febrile illness and normalized blood counts, suggesting the patient is in good condition. It explicitly states that no malignancy was identified, ruling out malignancy.",
      "findings": [
        "resolved febrile illness",
        "blood counts normalized",
        "no organomegaly",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 63,
      "timestamp": "2026-01-10T18:24:08.432753"
    },
    {
      "sample_idx": 64,
      "input": "29/09/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 29/09/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy, which is a benign finding. The report also states that no atypical features are present and no malignancy is identified. Therefore, malignancy is ruled out.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly mentions lymphadenopathy. The report also states that no atypical features are present and no malignancy is identified. Therefore, malignancy is ruled out.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly mentions lymphadenopathy. The report also states that no atypical features are present and no malignancy is identified. Therefore, malignancy is ruled out.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly mentions lymphadenopathy. The report also states that no atypical features are present and no malignancy is identified. Therefore, malignancy is ruled out.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly mentions lymphadenopathy. The report also states that no atypical features are present and no malignancy is identified. Therefore, malignancy is ruled out.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly mentions reactive lymphadenopathy, which is a benign finding. The report also states that no atypical features are present and no malignancy is identified. Therefore, malignancy is ruled out.",
      "findings": [
        "reactive lymphadenopathy",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 64,
      "timestamp": "2026-01-10T18:24:08.432764"
    },
    {
      "sample_idx": 65,
      "input": "09/06/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 09/06/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report describes an intraocular mass with calcifications, bilateral disease, positive family history, and a detected RB1 germline mutation, strongly suggesting retinoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report describes an intraocular mass with calcifications, bilateral disease, positive family history, and a detected RB1 germline mutation, strongly suggesting retinoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report describes an intraocular mass with calcifications, bilateral disease, positive family history, and a detected RB1 germline mutation, strongly suggesting retinoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report describes an intraocular mass with calcifications, bilateral disease, positive family history, and a detected RB1 germline mutation, strongly suggesting retinoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report describes an intraocular",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes an intraocular mass with calcifications, bilateral disease, positive family history, and a detected RB1 germline mutation, strongly suggesting retinoblastoma.",
      "findings": [
        "intraocular mass with calcifications",
        "bilateral disease",
        "family history positive",
        "RB1 germline mutation detected"
      ],
      "fracture_mentioned": null,
      "idx": 65,
      "timestamp": "2026-01-10T18:24:08.432776"
    },
    {
      "sample_idx": 66,
      "input": "16/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are indicative of Neuroblastoma. The stage of the disease is also specified as Stage III, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are indicative of Neuroblastoma. The stage of the disease is also specified as Stage III, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are indicative of Neuroblastoma. The stage of the disease is also specified as Stage III, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are indicative of Neuroblastoma. The stage of the disease is also specified as Stage III, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are indicative of Neuroblastoma. The stage of the disease is also specified as Stage III, confirming malignancy.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "elevated urinary catecholamines",
        "Stage III disease"
      ],
      "fracture_mentioned": null,
      "idx": 66,
      "timestamp": "2026-01-10T18:24:08.432789"
    },
    {
      "sample_idx": 67,
      "input": "21/03/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates normal blood counts, the absence of blast cells, adequate platelets, and normal hemoglobin, with no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates normal blood counts, the absence of blast cells, adequate platelets, and normal hemoglobin, with no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates normal blood counts, the absence of blast cells, adequate platelets, and normal hemoglobin, with no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates normal blood counts, the absence of blast cells, adequate platelets, and normal hemoglobin, with no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates normal blood counts, the absence",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report indicates normal blood counts, the absence of blast cells, adequate platelets, and normal hemoglobin, with no evidence of malignancy.",
      "findings": [
        "normal CBC with age-appropriate values",
        "no blast cells",
        "platelets adequate",
        "hemoglobin within normal limits",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 67,
      "timestamp": "2026-01-10T18:24:08.432800"
    },
    {
      "sample_idx": 68,
      "input": "27/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\", \"parameningeal mass with intracranial extension\"],\n        \"rationale\": \"The report explicitly mentions embryonal rhabdomyosarcoma, a type of cancer, along with a parameningeal mass with intracranial extension. This strongly indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\"],\n        \"rationale\": \"The report explicitly mentions embryonal rhabdomyosarcoma, a type of cancer. This strongly indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\"],\n        \"rationale\": \"The report explicitly mentions parameningeal mass with intracranial extension, indicating a malignant process.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\"],\n        \"rationale\": \"The report explicitly mentions embryonal rhabdomyosarcoma, a type of cancer. This strongly indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\"],\n        \"rationale\": \"The report explicitly mentions embryonal rhabdomyosarcoma, a type of cancer. This strongly indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\"],\n        \"rationale\": \"The report explicitly mentions embryonal rhabdomyosarcoma, a type of cancer. This strongly indicates malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly mentions embryonal rhabdomyosarcoma, a type of cancer, along with a parameningeal mass with intracranial extension. This strongly indicates malignancy.",
      "findings": [
        "embryonal rhabdomyosarcoma",
        "parameningeal mass with intracranial extension"
      ],
      "fracture_mentioned": null,
      "idx": 68,
      "timestamp": "2026-01-10T18:24:08.432811"
    },
    {
      "sample_idx": 69,
      "input": "16/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 16/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified on the chest radiograph and other imaging, providing reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified on the chest radiograph and other imaging, providing reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified on the chest radiograph and other imaging, providing reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified on the chest radiograph and other imaging, providing reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified on the chest radiograph and other imaging, providing reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\":",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that no malignancy was identified on the chest radiograph and other imaging, providing reassurance.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 69,
      "timestamp": "2026-01-10T18:24:08.432821"
    },
    {
      "sample_idx": 70,
      "input": "29/11/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 29/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report explicitly mentions an intraocular mass with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, which are all indicative of retinoblastoma, a type of eye cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report explicitly mentions an intraocular mass with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, which are all indicative of retinoblastoma, a type of eye cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report explicitly mentions an intraocular mass with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, which are all indicative of retinoblastoma, a type of eye cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report explicitly mentions an intraocular mass with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, which are all indicative of retinoblastoma, a type of eye cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly mentions an intraocular mass with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, which are all indicative of retinoblastoma, a type of eye cancer.",
      "findings": [
        "intraocular mass with calcifications",
        "bilateral disease",
        "family history positive",
        "RB1 germline mutation detected"
      ],
      "fracture_mentioned": null,
      "idx": 70,
      "timestamp": "2026-01-10T18:24:08.432834"
    },
    {
      "sample_idx": 71,
      "input": "11/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 11/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy with bulky anterior mediastinal mass\", \"PET-CT showing FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly describes mediastinal lymphadenopathy and FDG-avid nodes, along with a diagnosis of Classical Hodgkin Lymphoma, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"Hodgkin Lymphoma\", \"nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions Hodgkin Lymphoma with nodular sclerosing type, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"Hodgkin Lymphoma\", \"nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions Hodgkin Lymphoma with nodular sclerosing type, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"Hodgkin Lymphoma\", \"nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions Hodgkin Lymphoma with nodular sclerosing type, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"Hodgkin Lymphoma\", \"nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions Hodgkin Lymphoma with nodular sclerosing type, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"Hodgkin Lymphoma\", \"nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions Hodgkin Lymphoma with nodular sclerosing type,",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly describes mediastinal lymphadenopathy and FDG-avid nodes, along with a diagnosis of Classical Hodgkin Lymphoma, confirming malignancy.",
      "findings": [
        "mediastinal lymphadenopathy with bulky anterior mediastinal mass",
        "PET-CT showing FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 71,
      "timestamp": "2026-01-10T18:24:08.432845"
    },
    {
      "sample_idx": 72,
      "input": "13/09/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 13/09/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"The report explicitly mentions a parameningeal mass with intracranial extension, confirming the diagnosis of embryonal rhabdomyosarcoma, which is a type of cancer. The negative PAX-FOXO1 fusion status is also relevant to the diagnosis and treatment planning.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"The report explicitly mentions a parameningeal mass with intracranial extension, confirming the diagnosis of embryonal rhabdomyosarcoma, which is a type of cancer. The negative PAX-FOXO1 fusion status is also relevant to the diagnosis and treatment planning.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"The report explicitly mentions a parameningeal mass with intracranial extension, confirming the diagnosis of embryonal rhabdomyosarcoma, which is a type of cancer. The negative PAX-FOXO1 fusion status is also relevant to the diagnosis and treatment planning.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"The report explicitly mentions a parameningeal mass with intracranial extension, confirming the diagnosis of embryonal rhabdomyosarcoma, which is a type of cancer. The negative PAX-FO",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly mentions a parameningeal mass with intracranial extension, confirming the diagnosis of embryonal rhabdomyosarcoma, which is a type of cancer. The negative PAX-FOXO1 fusion status is also relevant to the diagnosis and treatment planning.",
      "findings": [
        "parameningeal mass with intracranial extension",
        "embryonal rhabdomyosarcoma on biopsy",
        "PAX-FOXO1 fusion negative"
      ],
      "fracture_mentioned": null,
      "idx": 72,
      "timestamp": "2026-01-10T18:24:08.432857"
    },
    {
      "sample_idx": 73,
      "input": "03/12/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 03/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly for age\", \"no focal lesions\", \"normal echo texture\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the spleen is enlarged due to age and that no focal lesions or malignancy were found.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly for age\", \"no focal lesions\", \"normal echo texture\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the spleen is enlarged due to age and that no focal lesions or malignancy were found.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly for age\", \"no focal lesions\", \"normal echo texture\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the spleen is enlarged due to age and that no focal lesions or malignancy were found.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly for age\", \"no focal lesions\", \"normal echo texture\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the spleen is enlarged due to age and that no focal lesions or malignancy were found.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly for age\", \"no focal lesions\", \"normal echo texture\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the spleen is enlarged due to age and that no focal lesions or malignancy were found.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly for age",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report states that the spleen is enlarged due to age and that no focal lesions or malignancy were found.",
      "findings": [
        "physiological splenomegaly for age",
        "no focal lesions",
        "normal echo texture",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 73,
      "timestamp": "2026-01-10T18:24:08.432885"
    },
    {
      "sample_idx": 74,
      "input": "11/10/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 11/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction\", \"large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report describes findings consistent with Ewing Sarcoma, including bone destruction, soft tissue mass, periosteal reaction, and EWSR1 fusion positivity, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction\", \"large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report describes findings consistent with Ewing Sarcoma, including bone destruction, soft tissue mass, periosteal reaction, and EWSR1 fusion positivity, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction\", \"large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report describes findings consistent with Ewing Sarcoma, including bone destruction, soft tissue mass, periosteal reaction, and EWSR1 fusion positivity, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction\", \"large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report describes findings consistent with Ewing Sarcoma, including bone destruction, soft tissue mass, periosteal reaction, and EWSR1 fusion positivity, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction\", \"large soft tissue mass",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes findings consistent with Ewing Sarcoma, including bone destruction, soft tissue mass, periosteal reaction, and EWSR1 fusion positivity, all of which are indicative of malignancy.",
      "findings": [
        "permeative bone destruction",
        "large soft tissue mass",
        "onion-skin periosteal reaction",
        "EWSR1 fusion positive"
      ],
      "fracture_mentioned": null,
      "idx": 74,
      "timestamp": "2026-01-10T18:24:08.432897"
    },
    {
      "sample_idx": 75,
      "input": "28/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 28/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"The report identifies reactive lymphadenopathy secondary to viral infection, with decreasing node size and no atypical features. The final statement explicitly indicates that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"The report identifies reactive lymphadenopathy secondary to viral infection, with decreasing node size and no atypical features. The final statement explicitly indicates that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"The report identifies reactive lymphadenopathy secondary to viral infection, with decreasing node size and no atypical features. The final statement explicitly indicates that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"The report identifies reactive lymphadenopathy secondary to viral infection, with decreasing node size and no atypical features. The final statement explicitly indicates that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"ration",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report identifies reactive lymphadenopathy secondary to viral infection, with decreasing node size and no atypical features. The final statement explicitly indicates that no malignancy was identified.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up",
        "No atypical features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 75,
      "timestamp": "2026-01-10T18:24:08.432909"
    },
    {
      "sample_idx": 76,
      "input": "02/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report describes normal CBC parameters, the absence of blast cells, and explicitly states that no malignancy is identified. The doctor provides reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates normal blood counts and specifically states no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states no malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states no malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states no malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"no blast cells\", \"platelets adequate\", \"hemoglobin",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes normal CBC parameters, the absence of blast cells, and explicitly states that no malignancy is identified. The doctor provides reassurance.",
      "findings": [
        "normal CBC with age-appropriate values",
        "no blast cells",
        "platelets adequate",
        "hemoglobin within normal limits",
        "no malignancy identified",
        "reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 76,
      "timestamp": "2026-01-10T18:24:08.432921"
    },
    {
      "sample_idx": 77,
      "input": "06/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 06/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes a healing fracture with normal findings and explicitly states that no malignancy was identified. The report also confirms reassurance was provided.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that there are no pathological features and no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates that there are no pathological features and no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly mentions no pathological features and no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates that there are no pathological features and no malignancy",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes a healing fracture with normal findings and explicitly states that no malignancy was identified. The report also confirms reassurance was provided.",
      "findings": [
        "healing fracture",
        "normal bone density",
        "no pathological features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 77,
      "timestamp": "2026-01-10T18:24:08.432932"
    },
    {
      "sample_idx": 78,
      "input": "27/02/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"The report explicitly states bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells and immunophenotyping consistent with B-cell ALL, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"The report explicitly states bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells and immunophenotyping consistent with B-cell ALL, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"The report explicitly states bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells and immunophenotyping consistent with B-cell ALL, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"The report explicitly states bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells and immunophenotyping consistent with B-cell ALL, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly states bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells and immunophenotyping consistent with B-cell ALL, confirming malignancy.",
      "findings": [
        "bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells",
        "Immunophenotyping consistent with B-cell ALL"
      ],
      "fracture_mentioned": null,
      "idx": 78,
      "timestamp": "2026-01-10T18:24:08.432944"
    },
    {
      "sample_idx": 79,
      "input": "17/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 17/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Post-viral lymphocytosis\", \"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\", \"No malignancy identified\"],\n        \"rationale\": \"The report notes post-viral lymphocytosis with atypical lymphocytes that are resolving, confirmed by Monospot and EBV serology. It explicitly states that no malignancy is identified. Therefore, the presence of atypical lymphocytes and the confirmation of the viral etiology, combined with the explicit statement of no malignancy, indicates abnormal findings, but not malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Post-viral lymphocytosis\", \"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\", \"No malignancy identified\"],\n        \"rationale\": \"The report notes post-viral lymphocytosis with atypical lymphocytes that are resolving, confirmed by Monospot and EBV serology. It explicitly states that no malignancy is identified. Therefore, the presence of atypical lymphocytes and the confirmation of the viral etiology, combined with the explicit statement of no malignancy, indicates abnormal findings, but not malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Post-viral lymphocytosis\", \"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\", \"No malignancy identified\"],\n        \"rationale\": \"The report notes post-viral lymphocytosis with atypical lymphocytes that are resolving, confirmed by Monospot and EBV serology. It explicitly states that no malignancy is identified. Therefore, the presence of atypical lymphocytes and the confirmation of the viral etiology, combined with the explicit statement of no malignancy, indicates abnormal findings, but not malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Post-viral lymphocytosis\", \"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\", \"No malignancy identified\"],\n        ",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report notes post-viral lymphocytosis with atypical lymphocytes that are resolving, confirmed by Monospot and EBV serology. It explicitly states that no malignancy is identified. Therefore, the presence of atypical lymphocytes and the confirmation of the viral etiology, combined with the explicit statement of no malignancy, indicates abnormal findings, but not malignancy.",
      "findings": [
        "Post-viral lymphocytosis",
        "Atypical lymphocytes resolving",
        "Monospot positive",
        "EBV serology confirms",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 79,
      "timestamp": "2026-01-10T18:24:08.432959"
    },
    {
      "sample_idx": 80,
      "input": "18/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 18/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there is no malignancy identified. Physiological splenomegaly and normal echo texture are benign findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there is no malignancy identified. Physiological splenomegaly and normal echo texture are benign findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there is no malignancy identified. Physiological splenomegaly and normal echo texture are benign findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there is no malignancy identified. Physiological splenomegaly and normal echo texture are benign findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there is no malignancy identified. Physiological splenomegaly and normal echo texture are benign findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that there is no malignancy identified. Physiological splenomegaly and normal echo texture are benign findings.",
      "findings": [
        "physiological splenomegaly",
        "no focal lesions",
        "normal echo texture",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 80,
      "timestamp": "2026-01-10T18:24:08.432969"
    },
    {
      "sample_idx": 81,
      "input": "11/06/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 11/06/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"benign soft tissue mass - lipoma\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states the finding of a benign lipoma and confirms the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lipoma\", \"no malignancy\"],\n        \"rationale\": \"The report identifies a lipoma and states that no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lipoma\", \"no malignancy\"],\n        \"rationale\": \"The report identifies a lipoma and states that no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lipoma\", \"no malignancy\"],\n        \"rationale\": \"The report identifies a lipoma and states that no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lipoma\", \"no malignancy\"],\n        \"rationale\": \"The report identifies a lipoma and states that no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lipoma\", \"no malignancy\"],\n        \"rationale\": \"The report identifies a lipoma and states that no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lipoma\", \"no malignancy\"],\n        \"rationale\": \"The report identifies a lipoma and states that no malignancy is present.\"\n    }",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states the finding of a benign lipoma and confirms the absence of malignancy.",
      "findings": [
        "benign soft tissue mass - lipoma",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 81,
      "timestamp": "2026-01-10T18:24:08.432978"
    },
    {
      "sample_idx": 82,
      "input": "27/12/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 27/12/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"No vascular invasion\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report describes a left renal mass, which is suggestive of Wilms tumor. The presence of a pseudocapsule, favorable histology, and Stage II classification strongly indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"No vascular invasion\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report describes a left renal mass, which is suggestive of Wilms tumor. The presence of a pseudocapsule, favorable histology, and Stage II classification strongly indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"No vascular invasion\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report describes a left renal mass, which is suggestive of Wilms tumor. The presence of a pseudocapsule, favorable histology, and Stage II classification strongly indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"No vascular invasion\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report describes a left renal mass, which is suggestive of Wilms tumor. The presence of a pseudocapsule, favorable histology, and Stage II classification strongly indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"No vascular invasion\", \"Favorable histology on biopsy\", \"Stage II\"],",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a left renal mass, which is suggestive of Wilms tumor. The presence of a pseudocapsule, favorable histology, and Stage II classification strongly indicate malignancy.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "No vascular invasion",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 82,
      "timestamp": "2026-01-10T18:24:08.432990"
    },
    {
      "sample_idx": 83,
      "input": "05/11/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 05/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase. These findings are suggestive of osteosarcoma, a type of bone cancer, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase. These findings are suggestive of osteosarcoma, a type of bone cancer, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase. These findings are suggestive of osteosarcoma, a type of bone cancer, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase. These findings are suggestive of osteosarcoma, a type of bone cancer, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        ",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a destructive lesion in the distal femur with soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase. These findings are suggestive of osteosarcoma, a type of bone cancer, indicating malignancy.",
      "findings": [
        "destructive lesion in distal femur with soft tissue component",
        "sunburst periosteal reaction",
        "elevated alkaline phosphatase"
      ],
      "fracture_mentioned": null,
      "idx": 83,
      "timestamp": "2026-01-10T18:24:08.433002"
    },
    {
      "sample_idx": 84,
      "input": "23/11/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 23/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"no pathological features\", \"normal bone density\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes a healing fracture with normal findings, ruling out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features and no malignancy is identified, thus ruling out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features and no malignancy is identified, thus ruling out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features and no malignancy is identified, thus ruling out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features and no malignancy is identified, thus ruling out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features and no malignancy is identified, thus ruling out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    ",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes a healing fracture with normal findings, ruling out malignancy.",
      "findings": [
        "healing fracture",
        "no pathological features",
        "normal bone density",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 84,
      "timestamp": "2026-01-10T18:24:08.433011"
    },
    {
      "sample_idx": 85,
      "input": "14/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 14/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal and that no malignancy is identified, indicating no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal and that no malignancy is identified, indicating no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal and that no malignancy is identified, indicating no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal and that no malignancy is identified, indicating no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal and that no malignancy is identified, indicating no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that the chest radiograph is normal and that no malignancy is identified, indicating no evidence of malignancy.",
      "findings": [
        "normal chest radiograph",
        "clear lung fields",
        "no mediastinal mass",
        "heart size normal",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 85,
      "timestamp": "2026-01-10T18:24:08.433022"
    },
    {
      "sample_idx": 86,
      "input": "11/06/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 11/06/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large hepatic mass, elevated AFP, a specific histology subtype (Fetal), and a stage (II), all suggestive of hepatoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large hepatic mass, elevated AFP, a specific histology subtype (Fetal), and a stage (II), all suggestive of hepatoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large hepatic mass, elevated AFP, a specific histology subtype (Fetal), and a stage (II), all suggestive of hepatoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large hepatic mass, elevated AFP, a specific histology subtype (Fetal), and a stage (II), all suggestive of hepatoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large hepatic mass, elevated AFP, a specific histology subtype (Fetal), and a stage (II),",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a large hepatic mass, elevated AFP, a specific histology subtype (Fetal), and a stage (II), all suggestive of hepatoblastoma.",
      "findings": [
        "large heterogeneous hepatic mass",
        "elevated AFP",
        "Fetal histology subtype",
        "PRETEXT stage II"
      ],
      "fracture_mentioned": null,
      "idx": 86,
      "timestamp": "2026-01-10T18:24:08.433032"
    },
    {
      "sample_idx": 87,
      "input": "16/12/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Acute Myeloid Leukemia.\n\nFrom clinical notes: Acute Myeloid Leukemia. Paediatric oncology assessment.\n\nFindings: myeloblasts accounting for 70% of marrow cellularity. Cytogenetic analysis reveals t(8;21) translocation. Favorable risk category. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 16/12/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"The report indicates 70% myeloblasts in the bone marrow and the presence of t(8;21) translocation, which are both indicators of acute myeloid leukemia (AML).\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"The report indicates 70% myeloblasts in the bone marrow and the presence of t(8;21) translocation, which are both indicators of acute myeloid leukemia (AML).\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"The report indicates 70% myeloblasts in the bone marrow and the presence of t(8;21) translocation, which are both indicators of acute myeloid leukemia (AML).\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"The report indicates 70% myeloblasts in the bone marrow and the presence of t(8;21) translocation, which are both indicators of acute myeloid leukemia (AML).\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        ",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report indicates 70% myeloblasts in the bone marrow and the presence of t(8;21) translocation, which are both indicators of acute myeloid leukemia (AML).",
      "findings": [
        "myeloblasts accounting for 70% of marrow cellularity",
        "t(8;21) translocation"
      ],
      "fracture_mentioned": null,
      "idx": 87,
      "timestamp": "2026-01-10T18:24:08.433042"
    },
    {
      "sample_idx": 88,
      "input": "29/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 29/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Stage II\"],\n        \"rationale\": \"The report mentions a large heterogeneous left renal mass with a pseudocapsule, which is suggestive of a Wilms Tumor. The report also mentions that the stage is II. This indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Stage II\"],\n        \"rationale\": \"The report mentions a large heterogeneous left renal mass with a pseudocapsule, which is suggestive of a Wilms Tumor. The report also mentions that the stage is II. This indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Stage II\"],\n        \"rationale\": \"The report mentions a large heterogeneous left renal mass with a pseudocapsule, which is suggestive of a Wilms Tumor. The report also mentions that the stage is II. This indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Stage II\"],\n        \"rationale\": \"The report mentions a large heterogeneous left renal mass with a pseudocapsule, which is suggestive of a Wilms Tumor. The report also mentions that the stage is II. This indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Stage II\"],\n        \"rationale\": \"The report mentions a large heterogeneous left renal mass with a pseudocapsule, which is suggestive of a Wilms Tumor. The report also mentions that the stage is II. This indicates malignancy.\"\n    }",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report mentions a large heterogeneous left renal mass with a pseudocapsule, which is suggestive of a Wilms Tumor. The report also mentions that the stage is II. This indicates malignancy.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 88,
      "timestamp": "2026-01-10T18:24:08.433053"
    },
    {
      "sample_idx": 89,
      "input": "16/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/01/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"CNS involvement negative\"],\n        \"rationale\": \"The report explicitly states bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells, and immunophenotyping consistent with B-cell ALL. CNS involvement is negative. These findings are highly suggestive of Acute Lymphoblastic Leukemia.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"CNS involvement negative\"],\n        \"rationale\": \"The report explicitly states bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells, and immunophenotyping consistent with B-cell ALL. CNS involvement is negative. These findings are highly suggestive of Acute Lymphoblastic Leukemia.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"CNS involvement negative\"],\n        \"rationale\": \"The report explicitly states bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells, and immunophenotyping consistent with B-cell ALL. CNS involvement is negative. These findings are highly suggestive of Acute Lymphoblastic Leukemia.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"CNS involvement negative\"],\n        \"rationale\": \"The report explicitly states bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells, and immunophenotyping consistent with B-cell ALL. CNS involvement is negative. These findings are highly suggestive of Acute Lymphoblastic",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly states bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells, and immunophenotyping consistent with B-cell ALL. CNS involvement is negative. These findings are highly suggestive of Acute Lymphoblastic Leukemia.",
      "findings": [
        "bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells",
        "Immunophenotyping consistent with B-cell ALL",
        "CNS involvement negative"
      ],
      "fracture_mentioned": null,
      "idx": 89,
      "timestamp": "2026-01-10T18:24:08.433066"
    },
    {
      "sample_idx": 90,
      "input": "06/09/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 06/09/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"Bilateral disease\", \"Family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report mentions intraocular masses with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, all of which are consistent with retinoblastoma, a type of eye cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"Bilateral disease\", \"Family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report mentions intraocular masses with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, all of which are consistent with retinoblastoma, a type of eye cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"Bilateral disease\", \"Family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report mentions intraocular masses with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, all of which are consistent with retinoblastoma, a type of eye cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"Bilateral disease\", \"Family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report mentions intraocular masses with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, all of which are consistent with retinoblastoma, a type of eye cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report mentions intraocular masses with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, all of which are consistent with retinoblastoma, a type of eye cancer.",
      "findings": [
        "intraocular mass with calcifications",
        "Bilateral disease",
        "Family history positive",
        "RB1 germline mutation detected"
      ],
      "fracture_mentioned": null,
      "idx": 90,
      "timestamp": "2026-01-10T18:24:08.433078"
    },
    {
      "sample_idx": 91,
      "input": "30/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 30/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates a healing fracture with normal bone density and no pathological features, thus ruling out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"ab",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report indicates a healing fracture with normal bone density and no pathological features, thus ruling out malignancy.",
      "findings": [
        "healing fracture",
        "normal bone density",
        "no pathological features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 91,
      "timestamp": "2026-01-10T18:24:08.433088"
    },
    {
      "sample_idx": 92,
      "input": "22/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 22/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign bone cyst - resolved\", \"No aggressive features\", \"Normal bone density\", \"No recurrence on imaging\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified and that the bone cyst is benign and resolved.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    ",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that no malignancy was identified and that the bone cyst is benign and resolved.",
      "findings": [
        "Benign bone cyst - resolved",
        "No aggressive features",
        "Normal bone density",
        "No recurrence on imaging",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 92,
      "timestamp": "2026-01-10T18:24:08.433099"
    },
    {
      "sample_idx": 93,
      "input": "04/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 04/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no pathological features or malignancy were identified. The healing fracture and normal bone density are also noted.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no pathological features or malignancy were identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no pathological features or malignancy were identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no pathological features or malignancy were identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no pathological features or malignancy were identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no pathological features or malignancy were identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that no pathological features or malignancy were identified. The healing fracture and normal bone density are also noted.",
      "findings": [
        "healing fracture",
        "normal bone density",
        "no pathological features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 93,
      "timestamp": "2026-01-10T18:24:08.433110"
    },
    {
      "sample_idx": 94,
      "input": "05/08/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 05/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the brain MRI was normal, and no mass lesion, abnormal enhancement, or malignancy was identified. Reassurance was provided.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the brain MRI was normal, and no mass lesion, abnormal enhancement, or malignancy was identified. Reassurance was provided.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the brain MRI was normal, and no mass lesion, abnormal enhancement, or malignancy was identified. Reassurance was provided.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the brain MRI was normal, and no mass lesion, abnormal enhancement, or malignancy was identified. Reassurance was provided.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that the brain MRI was normal, and no mass lesion, abnormal enhancement, or malignancy was identified. Reassurance was provided.",
      "findings": [
        "normal brain MRI",
        "no mass lesion",
        "no abnormal enhancement",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 94,
      "timestamp": "2026-01-10T18:24:08.433121"
    },
    {
      "sample_idx": 95,
      "input": "10/03/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 10/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"no pathological features\", \"normal bone density\", \"trauma history consistent\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features, no malignancy identified, and the fracture is healing normally. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features and no malignancy identified. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features and no malignancy identified. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features and no malignancy identified. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features and no malignancy identified. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features and no malignancy identified. Therefore, there",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that there are no pathological features, no malignancy identified, and the fracture is healing normally. Therefore, there is no evidence of malignancy.",
      "findings": [
        "healing fracture",
        "no pathological features",
        "normal bone density",
        "trauma history consistent",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 95,
      "timestamp": "2026-01-10T18:24:08.433132"
    },
    {
      "sample_idx": 96,
      "input": "28/09/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 28/09/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and confirms the diagnosis of Classical Hodgkin Lymphoma, nodular sclerosing type, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and confirms the diagnosis of Classical Hodgkin Lymphoma, nodular sclerosing type, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and confirms the diagnosis of Classical Hodgkin Lymphoma, nodular sclerosing type, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and confirms the diagnosis of Classical Hodgkin Lymphoma, nodular sclerosing type, indicating malignancy.\"\n    }\n}\n```\n```json",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and confirms the diagnosis of Classical Hodgkin Lymphoma, nodular sclerosing type, indicating malignancy.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 96,
      "timestamp": "2026-01-10T18:24:08.433144"
    },
    {
      "sample_idx": 97,
      "input": "02/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Brain Tumor - Glioma.\n\nFrom clinical notes: Brain Tumor - Glioma. Paediatric oncology assessment.\n\nFindings: left temporal lobe infiltrative mass with mass effect. FLAIR hyperintensity. Biopsy confirms diffuse astrocytoma WHO grade II. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 02/01/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"left temporal lobe infiltrative mass with mass effect\", \"FLAIR hyperintensity\", \"biopsy confirms diffuse astrocytoma WHO grade II\"],\n        \"rationale\": \"The report mentions an infiltrative mass in the left temporal lobe with mass effect and FLAIR hyperintensity, and a biopsy confirms a diffuse astrocytoma, which is a type of brain tumor. The WHO grade II classification indicates a less aggressive form of astrocytoma. Therefore, the findings suggest malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"left temporal lobe infiltrative mass with mass effect\", \"FLAIR hyperintensity\", \"biopsy confirms diffuse astrocytoma WHO grade II\"],\n        \"rationale\": \"The report mentions an infiltrative mass in the left temporal lobe with mass effect and FLAIR hyperintensity, and a biopsy confirms a diffuse astrocytoma, which is a type of brain tumor. The WHO grade II classification indicates a less aggressive form of astrocytoma. Therefore, the findings suggest malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"left temporal lobe infiltrative mass with mass effect\", \"FLAIR hyperintensity\", \"biopsy confirms diffuse astrocytoma WHO grade II\"],\n        \"rationale\": \"The report mentions an infiltrative mass in the left temporal lobe with mass effect and FLAIR hyperintensity, and a biopsy confirms a diffuse astrocytoma, which is a type of brain tumor. The WHO grade II classification indicates a less aggressive form of astrocytoma. Therefore, the findings suggest malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"left temporal lobe infiltrative mass with mass effect\", \"FLAIR hyperintensity\", \"biopsy confirms diffuse astrocytoma WHO grade II\"],\n        \"rationale\": \"The report mentions an infiltrative mass in the",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report mentions an infiltrative mass in the left temporal lobe with mass effect and FLAIR hyperintensity, and a biopsy confirms a diffuse astrocytoma, which is a type of brain tumor. The WHO grade II classification indicates a less aggressive form of astrocytoma. Therefore, the findings suggest malignancy.",
      "findings": [
        "left temporal lobe infiltrative mass with mass effect",
        "FLAIR hyperintensity",
        "biopsy confirms diffuse astrocytoma WHO grade II"
      ],
      "fracture_mentioned": null,
      "idx": 97,
      "timestamp": "2026-01-10T18:24:08.433158"
    },
    {
      "sample_idx": 98,
      "input": "29/06/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 29/06/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes normal blood counts with no blast cells, indicating no evidence of malignancy. The findings are reassuring.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes normal blood counts with no blast cells, indicating no evidence of malignancy. The findings are reassuring.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes normal blood counts with no blast cells, indicating no evidence of malignancy. The findings are reassuring.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes normal blood counts with no blast cells, indicating no evidence of malignancy. The findings are reassuring.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes normal blood counts with no blast cells, indicating no evidence of malignancy. The findings are reassuring.\"\n    }",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes normal blood counts with no blast cells, indicating no evidence of malignancy. The findings are reassuring.",
      "findings": [
        "normal CBC with age-appropriate values",
        "no blast cells",
        "platelets adequate",
        "hemoglobin within normal limits",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 98,
      "timestamp": "2026-01-10T18:24:08.433169"
    },
    {
      "sample_idx": 99,
      "input": "21/03/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"FDG-avid nodes\", \"nodular sclerosing type\"],\n        \"rationale\": \"The report describes mediastinal lymphadenopathy, FDG-avid nodes, and a nodular sclerosing type of Hodgkin Lymphoma, all of which indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"FDG-avid nodes\", \"nodular sclerosing type\"],\n        \"rationale\": \"The report describes mediastinal lymphadenopathy, FDG-avid nodes, and a nodular sclerosing type of Hodgkin Lymphoma, all of which indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"FDG-avid nodes\", \"nodular sclerosing type\"],\n        \"rationale\": \"The report describes mediastinal lymphadenopathy, FDG-avid nodes, and a nodular sclerosing type of Hodgkin Lymphoma, all of which indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"FDG-avid nodes\", \"nodular sclerosing type\"],\n        \"rationale\": \"The report describes mediastinal lymphadenopathy, FDG-avid nodes, and a nodular sclerosing type of Hodgkin Lymphoma, all of which indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"FDG-avid nodes\", \"nodular sclerosing type\"],\n        \"rationale\": \"The report describes mediastinal lymphadenopathy, FDG-avid nodes, and a nodular sclerosing type",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes mediastinal lymphadenopathy, FDG-avid nodes, and a nodular sclerosing type of Hodgkin Lymphoma, all of which indicate malignancy.",
      "findings": [
        "mediastinal lymphadenopathy",
        "FDG-avid nodes",
        "nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 99,
      "timestamp": "2026-01-10T18:24:08.433179"
    }
  ],
  "num_samples": 100,
  "samples": [
    {
      "sample_idx": 0,
      "input": "02/01/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 02/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"normalized blood counts\", \"no organomegaly\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified, and that the patient is in clinical improvement.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"normalized blood counts\", \"no organomegaly\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified, and that the patient is in clinical improvement.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"normalized blood counts\", \"no organomegaly\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified, and that the patient is in clinical improvement.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"normalized blood counts\", \"no organomegaly\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified, and that the patient is in clinical improvement.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"normalized blood counts\", \"no organomegaly\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified, and that the patient is in clinical improvement.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"normalized blood counts\", \"no organomegaly\", \"no malignancy identified\"],",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that no malignancy was identified, and that the patient is in clinical improvement.",
      "findings": [
        "resolved febrile illness",
        "normalized blood counts",
        "no organomegaly",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 0,
      "timestamp": "2026-01-10T18:24:08.431990"
    },
    {
      "sample_idx": 1,
      "input": "26/10/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 26/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report explicitly states a posterior fossa mass with enhancement and hydrocephalus, restricted diffusion, and high-grade medulloblastoma on histology, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report explicitly states a posterior fossa mass with enhancement and hydrocephalus, restricted diffusion, and high-grade medulloblastoma on histology, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report explicitly states a posterior fossa mass with enhancement and hydrocephalus, restricted diffusion, and high-grade medulloblastoma on histology, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report explicitly states a posterior fossa mass with enhancement and hydrocephalus, restricted diffusion, and high-grade medulloblastoma on histology, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report explicitly states a posterior fossa mass with enhancement and hydrocephalus, restricted diffusion, and high-grade medullo",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly states a posterior fossa mass with enhancement and hydrocephalus, restricted diffusion, and high-grade medulloblastoma on histology, indicating malignancy.",
      "findings": [
        "posterior fossa mass with enhancement and hydrocephalus",
        "Restricted diffusion",
        "High-grade medulloblastoma on histology"
      ],
      "fracture_mentioned": null,
      "idx": 1,
      "timestamp": "2026-01-10T18:24:08.432015"
    },
    {
      "sample_idx": 2,
      "input": "03/07/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 03/07/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"node size decreasing on follow-up\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign condition. No atypical features or malignancy is identified, and the node size is decreasing on follow-up.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign condition. No atypical features or malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign condition. No atypical features or malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign condition. No atypical features or malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign condition. No atypical features or malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes reactive lymphadenopathy, which is a benign condition. No atypical features or malignancy is identified, and the node size is decreasing on follow-up.",
      "findings": [
        "reactive lymphadenopathy",
        "node size decreasing on follow-up",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 2,
      "timestamp": "2026-01-10T18:24:08.432030"
    },
    {
      "sample_idx": 3,
      "input": "27/02/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Non-Hodgkin Lymphoma.\n\nFrom clinical notes: Non-Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: abdominal lymphadenopathy with mesenteric and retroperitoneal nodes. Burkitt lymphoma confirmed on biopsy. High LDH levels. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"The report explicitly states the presence of abdominal lymphadenopathy, mesenteric and retroperitoneal nodes, confirmed Burkitt lymphoma on biopsy, and elevated LDH levels. These findings strongly indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"The report explicitly states the presence of abdominal lymphadenopathy, mesenteric and retroperitoneal nodes, confirmed Burkitt lymphoma on biopsy, and elevated LDH levels. These findings strongly indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"The report explicitly states the presence of abdominal lymphadenopathy, mesenteric and retroperitoneal nodes, confirmed Burkitt lymphoma on biopsy, and elevated LDH levels. These findings strongly indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"The report explicitly states the presence of abdominal lymphadenopathy, mesenteric and retroperitoneal nodes, confirmed Burkitt lymphoma on biopsy, and elevated LDH levels. These findings strongly indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\",",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly states the presence of abdominal lymphadenopathy, mesenteric and retroperitoneal nodes, confirmed Burkitt lymphoma on biopsy, and elevated LDH levels. These findings strongly indicate malignancy.",
      "findings": [
        "abdominal lymphadenopathy",
        "mesenteric and retroperitoneal nodes",
        "Burkitt lymphoma confirmed on biopsy",
        "high LDH levels"
      ],
      "fracture_mentioned": null,
      "idx": 3,
      "timestamp": "2026-01-10T18:24:08.432044"
    },
    {
      "sample_idx": 4,
      "input": "04/05/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 04/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"The report explicitly describes bone marrow infiltration with lymphoblasts (85%) and confirms the B-cell ALL immunophenotype, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"The report explicitly describes bone marrow infiltration with lymphoblasts (85%) and confirms the B-cell ALL immunophenotype, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"The report explicitly describes bone marrow infiltration with lymphoblasts (85%) and confirms the B-cell ALL immunophenotype, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"The report explicitly describes bone marrow infiltration with lymphoblasts (85%) and confirms the B-cell ALL immunophenotype, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"The report explicitly describes bone marrow infiltration with lymphoblasts (85%) and confirms",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly describes bone marrow infiltration with lymphoblasts (85%) and confirms the B-cell ALL immunophenotype, indicating malignancy.",
      "findings": [
        "bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells",
        "Immunophenotyping consistent with B-cell ALL"
      ],
      "fracture_mentioned": null,
      "idx": 4,
      "timestamp": "2026-01-10T18:24:08.432056"
    },
    {
      "sample_idx": 5,
      "input": "17/09/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 17/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly describes reactive lymphadenopathy, which is a non-cancerous condition. It also confirms that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes lymphadenopathy, which could be due to various causes, including infection or inflammation. The report explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes lymphadenopathy, which could be due to various causes, including infection or inflammation. The report explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes lymphadenopathy, which could be due to various causes, including infection or inflammation. The report explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes lymphadenopathy, which could be due to various causes, including infection or inflammation. The report explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes lymphadenopathy,",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly describes reactive lymphadenopathy, which is a non-cancerous condition. It also confirms that no malignancy was identified.",
      "findings": [
        "reactive lymphadenopathy",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 5,
      "timestamp": "2026-01-10T18:24:08.432068"
    },
    {
      "sample_idx": 6,
      "input": "11/07/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 11/07/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a large suprarenal mass with calcifications, MIBG avidity, elevated urinary catecholamines, and a Stage III diagnosis, all suggestive of neuroblastoma, a type of cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a large suprarenal mass with calcifications, MIBG avidity, elevated urinary catecholamines, and a Stage III diagnosis, all suggestive of neuroblastoma, a type of cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a large suprarenal mass with calcifications, MIBG avidity, elevated urinary catecholamines, and a Stage III diagnosis, all suggestive of neuroblastoma, a type of cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a large suprarenal mass with calcifications, MIBG avidity, elevated urinary catecholamines, and a Stage III diagnosis, all suggestive of neuroblastoma, a type of cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a large suprarenal mass with calcifications, MIBG avidity, elevated urinary catecholamines, and a Stage III diagnosis, all suggestive of neuroblastoma, a type of cancer.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "elevated urinary catecholamines",
        "Stage III disease"
      ],
      "fracture_mentioned": null,
      "idx": 6,
      "timestamp": "2026-01-10T18:24:08.432081"
    },
    {
      "sample_idx": 7,
      "input": "21/03/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified on the chest radiograph, lung fields, mediastinum, or heart. Reassurance was provided, indicating no concern for malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified on the chest radiograph, lung fields, mediastinum, or heart. Reassurance was provided, indicating no concern for malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified on the chest radiograph, lung fields, mediastinum, or heart. Reassurance was provided, indicating no concern for malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified on the chest radiograph, lung fields, mediastinum, or heart. Reassurance was provided, indicating no concern for malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        ",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that no malignancy was identified on the chest radiograph, lung fields, mediastinum, or heart. Reassurance was provided, indicating no concern for malignancy.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 7,
      "timestamp": "2026-01-10T18:24:08.432104"
    },
    {
      "sample_idx": 8,
      "input": "08/02/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 08/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\", \"No malignancy identified\"],\n        \"rationale\": \"The report states that the CBC is normal with age-appropriate values, no blast cells are present, and no malignancy is identified. Therefore, no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\", \"No malignancy identified\"],\n        \"rationale\": \"The report states that the CBC is normal with age-appropriate values, no blast cells are present, and no malignancy is identified. Therefore, no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\", \"No malignancy identified\"],\n        \"rationale\": \"The report states that the CBC is normal with age-appropriate values, no blast cells are present, and no malignancy is identified. Therefore, no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\", \"No malignancy identified\"],\n        \"rationale\": \"The report states that the CBC is normal with age-appropriate values, no blast cells are present, and no malignancy is identified. Therefore, no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"Platelets adequate\", \"Hem",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report states that the CBC is normal with age-appropriate values, no blast cells are present, and no malignancy is identified. Therefore, no malignancy is present.",
      "findings": [
        "Normal CBC with age-appropriate values",
        "No blast cells",
        "Platelets adequate",
        "Hemoglobin within normal limits",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 8,
      "timestamp": "2026-01-10T18:24:08.432118"
    },
    {
      "sample_idx": 9,
      "input": "25/04/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 25/04/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Stage II\", \"Favorable histology on biopsy\"],\n        \"rationale\": \"The report describes a large left renal mass with pseudocapsule, and the histology is favorable, indicating a Wilms tumor, a type of kidney cancer, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Stage II\", \"Favorable histology on biopsy\"],\n        \"rationale\": \"The report describes a large left renal mass with pseudocapsule, and the histology is favorable, indicating a Wilms tumor, a type of kidney cancer, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Stage II\", \"Favorable histology on biopsy\"],\n        \"rationale\": \"The report describes a large left renal mass with pseudocapsule, and the histology is favorable, indicating a Wilms tumor, a type of kidney cancer, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Stage II\", \"Favorable histology on biopsy\"],\n        \"rationale\": \"The report describes a large left renal mass with pseudocapsule, and the histology is favorable, indicating a Wilms tumor, a type of kidney cancer, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Stage II\", \"Favorable histology on biopsy\"],\n        \"rationale\": \"The report describes a large left renal mass with pseudocapsule, and the histology is favorable, indicating a Wil",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a large left renal mass with pseudocapsule, and the histology is favorable, indicating a Wilms tumor, a type of kidney cancer, confirming malignancy.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "Stage II",
        "Favorable histology on biopsy"
      ],
      "fracture_mentioned": null,
      "idx": 9,
      "timestamp": "2026-01-10T18:24:08.432131"
    },
    {
      "sample_idx": 10,
      "input": "26/12/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 26/12/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and confirms the diagnosis of Classical Hodgkin Lymphoma, nodular sclerosing type. This indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and confirms the diagnosis of Classical Hodgkin Lymphoma, nodular sclerosing type. This indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and confirms the diagnosis of Classical Hodgkin Lymphoma, nodular sclerosing type. This indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and confirms the diagnosis of Classical Hodgkin Lymphoma, nodular sclerosing type. This indicates malignancy.\"\n    }\n}\n",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and confirms the diagnosis of Classical Hodgkin Lymphoma, nodular sclerosing type. This indicates malignancy.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 10,
      "timestamp": "2026-01-10T18:24:08.432144"
    },
    {
      "sample_idx": 11,
      "input": "18/09/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 18/09/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, consistent with neuroblastoma. The stage III diagnosis further supports the presence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, consistent with neuroblastoma. The stage III diagnosis further supports the presence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, consistent with neuroblastoma. The stage III diagnosis further supports the presence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, consistent with neuroblastoma. The stage III diagnosis further supports the presence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, consistent with neuroblastoma. The stage III diagnosis further supports the presence of malignancy.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "elevated urinary catecholamines",
        "Stage III disease"
      ],
      "fracture_mentioned": null,
      "idx": 11,
      "timestamp": "2026-01-10T18:24:08.432157"
    },
    {
      "sample_idx": 12,
      "input": "15/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 15/12/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous hepatic mass with elevated AFP and a fetal histology subtype, indicating Hepatoblastoma. The PRETEXT stage II further supports the diagnosis of Hepatoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous hepatic mass with elevated AFP and a fetal histology subtype, indicating Hepatoblastoma. The PRETEXT stage II further supports the diagnosis of Hepatoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous hepatic mass with elevated AFP and a fetal histology subtype, indicating Hepatoblastoma. The PRETEXT stage II further supports the diagnosis of Hepatoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous hepatic mass with elevated AFP and a fetal histology subtype, indicating Hepatoblastoma. The PRETEXT stage II further supports the diagnosis of Hepatoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous hepatic mass with",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a large heterogeneous hepatic mass with elevated AFP and a fetal histology subtype, indicating Hepatoblastoma. The PRETEXT stage II further supports the diagnosis of Hepatoblastoma.",
      "findings": [
        "large heterogeneous hepatic mass",
        "elevated AFP",
        "Fetal histology subtype",
        "PRETEXT stage II"
      ],
      "fracture_mentioned": null,
      "idx": 12,
      "timestamp": "2026-01-10T18:24:08.432169"
    },
    {
      "sample_idx": 13,
      "input": "26/02/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Langerhans Cell Histiocytosis.\n\nFrom clinical notes: Langerhans Cell Histiocytosis. Paediatric oncology assessment.\n\nFindings: multiple lytic skull lesions with soft tissue component. CD1a and Langerin positive. Multisystem disease. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 26/02/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"multiple lytic skull lesions\", \"CD1a and Langerin positive\"],\n        \"rationale\": \"The report describes multiple lytic skull lesions with positive CD1a and Langerin staining, consistent with Langerhans Cell Histiocytosis, which is a type of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"Langerhans Cell Histiocytosis\", \"multisystem disease\"],\n        \"rationale\": \"The report explicitly mentions Langerhans Cell Histiocytosis, which is a known malignancy, and also indicates multisystem disease.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"Lytic skull lesions\", \"CD1a and Langerin positive\"],\n        \"rationale\": \"The report mentions lytic skull lesions and positive CD1a and Langerin staining, which are characteristic findings of Langerhans Cell Histiocytosis, a type of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"Langerhans Cell Histiocytosis\", \"multisystem disease\"],\n        \"rationale\": \"The report indicates Langerhans Cell Histiocytosis, a known malignancy, and also mentions multisystem disease, suggesting a systemic process.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"multiple lytic skull lesions\", \"CD1a and Langerin positive\"],\n        \"rationale\": \"The report explicitly mentions lytic skull lesions and positive CD1a and Langerin staining, which are characteristic findings of Langerhans Cell Histiocytosis, a type of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        ",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes multiple lytic skull lesions with positive CD1a and Langerin staining, consistent with Langerhans Cell Histiocytosis, which is a type of malignancy.",
      "findings": [
        "multiple lytic skull lesions",
        "CD1a and Langerin positive"
      ],
      "fracture_mentioned": null,
      "idx": 13,
      "timestamp": "2026-01-10T18:24:08.432180"
    },
    {
      "sample_idx": 14,
      "input": "08/09/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 08/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"no malignancy identified\"],\n        \"rationale\": \"The report identifies post-viral lymphocytosis, resolving atypical lymphocytes, and confirms EBV serology. No malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"no malignancy identified\"],\n        \"rationale\": \"The report identifies post-viral lymphocytosis, resolving atypical lymphocytes, and confirms EBV serology. No malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"no malignancy identified\"],\n        \"rationale\": \"The report identifies post-viral lymphocytosis, resolving atypical lymphocytes, and confirms EBV serology. No malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"no malignancy identified\"],\n        \"rationale\": \"The report identifies post-viral lymphocytosis, resolving atypical lymphocytes, and confirms EBV serology. No malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"no malignancy identified\"],\n        \"rationale\": \"The report identifies post-viral lymphocytosis, resolving",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report identifies post-viral lymphocytosis, resolving atypical lymphocytes, and confirms EBV serology. No malignancy is identified.",
      "findings": [
        "post-viral lymphocytosis",
        "atypical lymphocytes resolving",
        "monospot positive",
        "EBV serology confirms",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 14,
      "timestamp": "2026-01-10T18:24:08.432191"
    },
    {
      "sample_idx": 15,
      "input": "14/07/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Acute Myeloid Leukemia.\n\nFrom clinical notes: Acute Myeloid Leukemia. Paediatric oncology assessment.\n\nFindings: myeloblasts accounting for 70% of marrow cellularity. Cytogenetic analysis reveals t(8;21) translocation. Favorable risk category. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 14/07/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"The report identifies myeloblasts comprising 70% of the bone marrow cellularity, which is a hallmark of acute myeloid leukemia. The presence of t(8;21) translocation further confirms the diagnosis of AML.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"The report identifies myeloblasts comprising 70% of the bone marrow cellularity, which is a hallmark of acute myeloid leukemia. The presence of t(8;21) translocation further confirms the diagnosis of AML.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"The report identifies myeloblasts comprising 70% of the bone marrow cellularity, which is a hallmark of acute myeloid leukemia. The presence of t(8;21) translocation further confirms the diagnosis of AML.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"The report identifies myeloblasts comprising 70% of the bone marrow cellularity, which is a hallmark of acute myeloid leukemia. The presence of t(8;21) translocation further confirms the diagnosis of AML.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report identifies myeloblasts comprising 70% of the bone marrow cellularity, which is a hallmark of acute myeloid leukemia. The presence of t(8;21) translocation further confirms the diagnosis of AML.",
      "findings": [
        "myeloblasts accounting for 70% of marrow cellularity",
        "t(8;21) translocation"
      ],
      "fracture_mentioned": null,
      "idx": 15,
      "timestamp": "2026-01-10T18:24:08.432202"
    },
    {
      "sample_idx": 16,
      "input": "07/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 07/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"The report explicitly identifies an embryonal rhabdomyosarcoma with parameningeal mass and intracranial extension, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"The report explicitly states that the biopsy shows embryonal rhabdomyosarcoma, which is a type of cancer. The PAX-FOXO1 fusion status is also noted, which is relevant to the diagnosis and treatment planning.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\", \"parameningeal mass with intracranial extension\"],\n        \"rationale\": \"The report explicitly identifies embryonal rhabdomyosarcoma, a type of cancer, along with a parameningeal mass with intracranial extension, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"The report states that the biopsy shows embryonal rhabdomyosarcoma, which is a type of cancer. The PAX-FOXO1 fusion status is also noted, which is relevant to the diagnosis and treatment planning.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\", \"parameningeal mass with intracranial extension\"],\n        \"rationale\": \"The report explicitly identifies embryonal rhabdomyosar",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies an embryonal rhabdomyosarcoma with parameningeal mass and intracranial extension, indicating malignancy.",
      "findings": [
        "parameningeal mass with intracranial extension",
        "embryonal rhabdomyosarcoma on biopsy",
        "PAX-FOXO1 fusion negative"
      ],
      "fracture_mentioned": null,
      "idx": 16,
      "timestamp": "2026-01-10T18:24:08.432213"
    },
    {
      "sample_idx": 17,
      "input": "06/04/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 06/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report confirms that the chest radiograph shows no signs of malignancy, and there are no abnormal findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report confirms that the chest radiograph shows no signs of malignancy, and there are no abnormal findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report confirms that the chest radiograph shows no signs of malignancy, and there are no abnormal findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report confirms that the chest radiograph shows no signs of malignancy, and there are no abnormal findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report confirms that the chest radiograph shows no signs of malignancy, and there are no abnormal findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report confirms that the chest radiograph shows no signs of malignancy, and there are no abnormal findings.",
      "findings": [
        "normal chest radiograph",
        "clear lung fields",
        "no mediastinal mass",
        "heart size normal",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 17,
      "timestamp": "2026-01-10T18:24:08.432224"
    },
    {
      "sample_idx": 18,
      "input": "23/05/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Bone pain. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 23/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report explicitly mentions a posterior fossa mass, restricted diffusion, and a diagnosis of high-grade medulloblastoma, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report explicitly mentions a posterior fossa mass, restricted diffusion, and a diagnosis of high-grade medulloblastoma, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report explicitly mentions a posterior fossa mass, restricted diffusion, and a diagnosis of high-grade medulloblastoma, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report explicitly mentions a posterior fossa mass, restricted diffusion, and a diagnosis of high-grade medulloblastoma, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report explicitly mentions a posterior fossa mass, restricted diffusion, and a diagnosis of high-grade medulloblastoma, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly mentions a posterior fossa mass, restricted diffusion, and a diagnosis of high-grade medulloblastoma, confirming malignancy.",
      "findings": [
        "posterior fossa mass with enhancement and hydrocephalus",
        "Restricted diffusion",
        "High-grade medulloblastoma on histology"
      ],
      "fracture_mentioned": null,
      "idx": 18,
      "timestamp": "2026-01-10T18:24:08.432235"
    },
    {
      "sample_idx": 19,
      "input": "09/07/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 09/07/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are indicative of neuroblastoma. Stage III disease further supports the diagnosis of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are indicative of neuroblastoma. Stage III disease further supports the diagnosis of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are indicative of neuroblastoma. Stage III disease further supports the diagnosis of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are indicative of neuroblastoma. Stage III disease further supports the diagnosis of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are indicative of neuroblastoma. Stage III disease further supports the diagnosis of malignancy.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "elevated urinary catecholamines",
        "Stage III disease"
      ],
      "fracture_mentioned": null,
      "idx": 19,
      "timestamp": "2026-01-10T18:24:08.432248"
    },
    {
      "sample_idx": 20,
      "input": "18/08/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/08/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report describes a left renal mass with features suggestive of Wilms Tumor, confirmed by favorable histology and Stage II. The presence of a renal mass and the stage are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report describes a left renal mass with features suggestive of Wilms Tumor, confirmed by favorable histology and Stage II. The presence of a renal mass and the stage are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report describes a left renal mass with features suggestive of Wilms Tumor, confirmed by favorable histology and Stage II. The presence of a renal mass and the stage are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report describes a left renal mass with features suggestive of Wilms Tumor, confirmed by favorable histology and Stage II. The presence of a renal mass and the stage are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a left renal mass with features suggestive of Wilms Tumor, confirmed by favorable histology and Stage II. The presence of a renal mass and the stage are indicative of malignancy.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "no vascular invasion",
        "favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 20,
      "timestamp": "2026-01-10T18:24:08.432260"
    },
    {
      "sample_idx": 21,
      "input": "13/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 13/03/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the brain MRI is normal, and there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the brain MRI is normal, and there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the brain MRI is normal, and there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the brain MRI is normal, and there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the brain MRI is normal, and there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that the brain MRI is normal, and there is no evidence of malignancy.",
      "findings": [
        "normal brain MRI",
        "no mass lesion",
        "no abnormal enhancement",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 21,
      "timestamp": "2026-01-10T18:24:08.432270"
    },
    {
      "sample_idx": 22,
      "input": "18/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report explicitly mentions a left renal mass with characteristics suggestive of Wilms Tumor, along with the absence of vascular invasion and favorable histology. This confirms the presence of a malignant renal tumor (Wilms Tumor) and its stage.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report explicitly mentions a left renal mass with characteristics suggestive of Wilms Tumor, along with the absence of vascular invasion and favorable histology. This confirms the presence of a malignant renal tumor (Wilms Tumor) and its stage.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report explicitly mentions a left renal mass with characteristics suggestive of Wilms Tumor, along with the absence of vascular invasion and favorable histology. This confirms the presence of a malignant renal tumor (Wilms Tumor) and its stage.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report explicitly mentions a left renal mass with characteristics suggestive of Wilms Tumor, along with the absence of vascular invasion and favorable histology. This confirms the presence of a malignant renal tumor (Wilms Tumor) and its stage.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly mentions a left renal mass with characteristics suggestive of Wilms Tumor, along with the absence of vascular invasion and favorable histology. This confirms the presence of a malignant renal tumor (Wilms Tumor) and its stage.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "no vascular invasion",
        "favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 22,
      "timestamp": "2026-01-10T18:24:08.432283"
    },
    {
      "sample_idx": 23,
      "input": "02/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report indicates normal brain MRI with no evidence of mass lesion, abnormal enhancement, or malignancy. The patient was reassured of the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report indicates normal brain MRI with no evidence of mass lesion, abnormal enhancement, or malignancy. The patient was reassured of the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report indicates normal brain MRI with no evidence of mass lesion, abnormal enhancement, or malignancy. The patient was reassured of the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report indicates normal brain MRI with no evidence of mass lesion, abnormal enhancement, or malignancy. The patient was reassured of the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report indicates normal brain MRI with no evidence of mass lesion, abnormal enhancement, or malignancy. The patient was reassured of the absence of",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report indicates normal brain MRI with no evidence of mass lesion, abnormal enhancement, or malignancy. The patient was reassured of the absence of malignancy.",
      "findings": [
        "normal brain MRI",
        "no mass lesion",
        "no abnormal enhancement",
        "no malignancy identified",
        "reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 23,
      "timestamp": "2026-01-10T18:24:08.432295"
    },
    {
      "sample_idx": 24,
      "input": "16/05/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report describes a normal brain MRI with no evidence of malignancy. Reassurance was provided, indicating no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified and reassurance was provided.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report specifically states that no mass lesion, abnormal enhancement, or malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report indicates a normal brain MRI without any signs of malignancy or other abnormalities.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report confirms that no malignancy was identified and provides reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified, and reassurance was given.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes a normal brain MRI with no evidence of malignancy. Reassurance was provided, indicating no malignancy was identified.",
      "findings": [
        "normal brain MRI",
        "no mass lesion",
        "no abnormal enhancement",
        "no malignancy identified",
        "reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 24,
      "timestamp": "2026-01-10T18:24:08.432305"
    },
    {
      "sample_idx": 25,
      "input": "16/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis\", \"large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report explicitly describes findings consistent with Ewing Sarcoma, including bone destruction, soft tissue mass, periosteal reaction, and EWSR1 fusion positivity, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis\", \"large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report explicitly describes findings consistent with Ewing Sarcoma, including bone destruction, soft tissue mass, periosteal reaction, and EWSR1 fusion positivity, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis\", \"large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report explicitly describes findings consistent with Ewing Sarcoma, including bone destruction, soft tissue mass, periosteal reaction, and EWSR1 fusion positivity, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis\", \"large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report explicitly describes findings consistent with Ewing Sarcoma, including bone destruction, soft tissue mass, periosteal reaction, and EWSR1 fusion positivity, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malign",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly describes findings consistent with Ewing Sarcoma, including bone destruction, soft tissue mass, periosteal reaction, and EWSR1 fusion positivity, all of which are indicative of malignancy.",
      "findings": [
        "permeative bone destruction in left femoral diaphysis",
        "large soft tissue mass",
        "onion-skin periosteal reaction",
        "EWSR1 fusion positive"
      ],
      "fracture_mentioned": null,
      "idx": 25,
      "timestamp": "2026-01-10T18:24:08.432319"
    },
    {
      "sample_idx": 26,
      "input": "13/08/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Non-Hodgkin Lymphoma.\n\nFrom clinical notes: Non-Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: abdominal lymphadenopathy with mesenteric and retroperitoneal nodes. Burkitt lymphoma confirmed on biopsy. High LDH levels. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 13/08/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"The report explicitly mentions abdominal lymphadenopathy, confirmation of Burkitt lymphoma on biopsy, and elevated LDH levels, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"The report explicitly mentions abdominal lymphadenopathy, confirmation of Burkitt lymphoma on biopsy, and elevated LDH levels, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"The report explicitly mentions abdominal lymphadenopathy, confirmation of Burkitt lymphoma on biopsy, and elevated LDH levels, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"The report explicitly mentions abdominal lymphadenopathy, confirmation of Burkitt lymphoma on biopsy, and elevated LDH levels, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"The report explicitly mentions abdominal lymphadenopathy",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly mentions abdominal lymphadenopathy, confirmation of Burkitt lymphoma on biopsy, and elevated LDH levels, all of which are indicative of malignancy.",
      "findings": [
        "abdominal lymphadenopathy",
        "mesenteric and retroperitoneal nodes",
        "Burkitt lymphoma confirmed on biopsy",
        "high LDH levels"
      ],
      "fracture_mentioned": null,
      "idx": 26,
      "timestamp": "2026-01-10T18:24:08.432330"
    },
    {
      "sample_idx": 27,
      "input": "25/06/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 25/06/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report mentions a healing fracture with no pathological features and explicitly states that no malignancy was identified. This suggests a non-malignant finding.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report mentions a healing fracture with no pathological features and explicitly states that no malignancy was identified. This suggests a non-malignant finding.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report mentions a healing fracture with no pathological features and explicitly states that no malignancy was identified. This suggests a non-malignant finding.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report mentions a healing fracture with no pathological features and explicitly states that no malignancy was identified. This suggests a non-malignant finding.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report mentions a healing fracture with no pathological features and explicitly states that no malignancy was identified. This suggests a non-malignant finding.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"no pathological features\", \"no malignancy identified\"],\n",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report mentions a healing fracture with no pathological features and explicitly states that no malignancy was identified. This suggests a non-malignant finding.",
      "findings": [
        "healing fracture",
        "no pathological features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 27,
      "timestamp": "2026-01-10T18:24:08.432341"
    },
    {
      "sample_idx": 28,
      "input": "01/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 01/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"benign bone cyst - resolved\", \"no aggressive features\", \"normal bone density\", \"no recurrence on imaging\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there is no malignancy identified. The resolution of a benign bone cyst and normal bone density further support the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that there is no malignancy identified. The resolution of a benign bone cyst and normal bone density further support the absence of malignancy.",
      "findings": [
        "benign bone cyst - resolved",
        "no aggressive features",
        "normal bone density",
        "no recurrence on imaging",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 28,
      "timestamp": "2026-01-10T18:24:08.432352"
    },
    {
      "sample_idx": 29,
      "input": "04/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 04/12/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are all suggestive of neuroblastoma. The report also mentions Stage III disease, further supporting the diagnosis of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are all suggestive of neuroblastoma. The report also mentions Stage III disease, further supporting the diagnosis of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are all suggestive of neuroblastoma. The report also mentions Stage III disease, further supporting the diagnosis of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are all suggestive of neuroblastoma. The report also mentions Stage III disease, further supporting the diagnosis of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are all suggestive of neuroblastoma. The report also mentions Stage III disease, further supporting the diagnosis of malignancy.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "elevated urinary catecholamines",
        "Stage III disease"
      ],
      "fracture_mentioned": null,
      "idx": 29,
      "timestamp": "2026-01-10T18:24:08.432365"
    },
    {
      "sample_idx": 30,
      "input": "15/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 15/07/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"restricted diffusion\", \"high-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report describes a posterior fossa mass with enhancement and hydrocephalus, restricted diffusion, and confirms high-grade medulloblastoma, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"restricted diffusion\", \"high-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report describes a posterior fossa mass with enhancement and hydrocephalus, restricted diffusion, and confirms high-grade medulloblastoma, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"restricted diffusion\", \"high-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report describes a posterior fossa mass with enhancement and hydrocephalus, restricted diffusion, and confirms high-grade medulloblastoma, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"restricted diffusion\", \"high-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report describes a posterior fossa mass with enhancement and hydrocephalus, restricted diffusion, and confirms high-grade medulloblastoma, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"restricted diffusion\", \"high-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report describes a posterior fossa mass with enhancement and hydrocephalus, restricted diffusion, and confirms high-grade medulloblastoma, indicating malignancy.\"\n    }\n}\n```\n",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a posterior fossa mass with enhancement and hydrocephalus, restricted diffusion, and confirms high-grade medulloblastoma, indicating malignancy.",
      "findings": [
        "posterior fossa mass with enhancement and hydrocephalus",
        "restricted diffusion",
        "high-grade medulloblastoma on histology"
      ],
      "fracture_mentioned": null,
      "idx": 30,
      "timestamp": "2026-01-10T18:24:08.432377"
    },
    {
      "sample_idx": 31,
      "input": "02/04/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 02/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates a normal chest radiograph with no signs of malignancy. The findings are reassuring and suggest no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates a normal chest radiograph with no signs of malignancy. The findings are reassuring and suggest no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates a normal chest radiograph with no signs of malignancy. The findings are reassuring and suggest no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates a normal chest radiograph with no signs of malignancy. The findings are reassuring and suggest no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates a normal chest radiograph with no signs of malignancy. The findings are reassuring and suggest no malignancy is present.\"\n    }\n}\n```\n```json",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report indicates a normal chest radiograph with no signs of malignancy. The findings are reassuring and suggest no malignancy is present.",
      "findings": [
        "normal chest radiograph",
        "clear lung fields",
        "no mediastinal mass",
        "heart size normal",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 31,
      "timestamp": "2026-01-10T18:24:08.432387"
    },
    {
      "sample_idx": 32,
      "input": "04/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"The report describes a sacrococcygeal mass, elevated tumor markers, and the presence of yolk sac tumor elements, all indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"The report describes a sacrococcygeal mass, elevated tumor markers, and the presence of yolk sac tumor elements, all indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"The report describes a sacrococcygeal mass, elevated tumor markers, and the presence of yolk sac tumor elements, all indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"The report describes a sacrococcygeal mass, elevated tumor markers, and the presence of yolk sac tumor elements, all indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"elevated AFP and beta-h",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a sacrococcygeal mass, elevated tumor markers, and the presence of yolk sac tumor elements, all indicative of malignancy.",
      "findings": [
        "sacrococcygeal mass with mixed solid and cystic components",
        "elevated AFP and beta-hCG",
        "yolk sac tumor elements present"
      ],
      "fracture_mentioned": null,
      "idx": 32,
      "timestamp": "2026-01-10T18:24:08.432398"
    },
    {
      "sample_idx": 33,
      "input": "24/11/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report describes mediastinal lymphadenopathy, a bulky anterior mediastinal mass, and FDG-avid nodes, all of which are indicative of Hodgkin Lymphoma, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"Hodgkin Lymphoma\", \"nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions Hodgkin Lymphoma and specifies its nodular sclerosing type, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"FDG-avid nodes\", \"bulky anterior mediastinal mass\"],\n        \"rationale\": \"The report explicitly identifies FDG-avid nodes and a bulky anterior mediastinal mass, which are indicators of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\"],\n        \"rationale\": \"The report mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, and FDG-avid nodes, which are all indicators of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"Hodgkin Lymphoma\", \"nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions Hodgkin Lymphoma and specifies its nodular sclerosing type, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes mediastinal lymphadenopathy, a bulky anterior mediastinal mass, and FDG-avid nodes, all of which are indicative of Hodgkin Lymphoma, confirming malignancy.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 33,
      "timestamp": "2026-01-10T18:24:08.432410"
    },
    {
      "sample_idx": 34,
      "input": "07/03/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 07/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no abnormal findings, no blast cells, and no malignancy. The CBC is normal. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no abnormal findings, no blast cells, and no malignancy. The CBC is normal. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no abnormal findings, no blast cells, and no malignancy. The CBC is normal. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no abnormal findings, no blast cells, and no malignancy. The CBC is normal. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hem",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that there are no abnormal findings, no blast cells, and no malignancy. The CBC is normal. Therefore, there is no evidence of malignancy.",
      "findings": [
        "normal CBC with age-appropriate values",
        "no blast cells",
        "platelets adequate",
        "hemoglobin within normal limits",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 34,
      "timestamp": "2026-01-10T18:24:08.432422"
    },
    {
      "sample_idx": 35,
      "input": "04/10/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"benign soft tissue mass - lipoma\", \"No malignancy identified\", \"Reassurance provided\"],\n        \"rationale\": \"The report confirms the presence of a benign lipoma and explicitly states that no malignancy was identified. The reassurance provided further supports the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"benign soft tissue mass - lipoma\", \"No malignancy identified\", \"Reassurance provided\"],\n        \"rationale\": \"The report confirms the presence of a benign lipoma and explicitly states that no malignancy was identified. The reassurance provided further supports the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"benign soft tissue mass - lipoma\", \"No malignancy identified\", \"Reassurance provided\"],\n        \"rationale\": \"The report confirms the presence of a benign lipoma and explicitly states that no malignancy was identified. The reassurance provided further supports the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"benign soft tissue mass - lipoma\", \"No malignancy identified\", \"Reassurance provided\"],\n        \"rationale\": \"The report confirms the presence of a benign lipoma and explicitly states that no malignancy was identified. The reassurance provided further supports the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"benign soft tissue mass - lipoma\", \"No malignancy identified\", \"Reassurance provided\"],\n        \"rationale\": \"The report confirms the presence of a benign lipoma and explicitly states that no malignancy was identified. The reassurance provided further supports the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report confirms the presence of a benign lipoma and explicitly states that no malignancy was identified. The reassurance provided further supports the absence of malignancy.",
      "findings": [
        "benign soft tissue mass - lipoma",
        "No malignancy identified",
        "Reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 35,
      "timestamp": "2026-01-10T18:24:08.432432"
    },
    {
      "sample_idx": 36,
      "input": "04/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph, lung fields, mediastinum, heart size, and bone marrow biopsy show no malignancy. The patient was reassured.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no abnormal findings\", \"normal bone marrow\", \"no evidence of malignancy\"],\n        \"rationale\": \"The report indicates that there are no abnormal findings in the bone marrow and no evidence of malignancy. The bone marrow is normal.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"normal bone marrow\"],\n        \"rationale\": \"The report explicitly states that there is no evidence of malignancy and the bone marrow is normal.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"normal bone marrow\"],\n        \"rationale\": \"The report explicitly states that there is no evidence of malignancy and the bone marrow is normal.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"normal bone marrow\"],\n        \"rationale\": \"The report explicitly states that there is no evidence of malignancy and the bone marrow is normal.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"normal bone marrow\"],\n        \"rationale\": \"The report explicitly states that there is no evidence of malignancy and the bone marrow is normal.\"\n    }\n",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that the chest radiograph, lung fields, mediastinum, heart size, and bone marrow biopsy show no malignancy. The patient was reassured.",
      "findings": [
        "normal chest radiograph",
        "clear lung fields",
        "no mediastinal mass",
        "heart size normal",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 36,
      "timestamp": "2026-01-10T18:24:08.432443"
    },
    {
      "sample_idx": 37,
      "input": "02/04/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 02/04/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur\", \"soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur, a soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase. These findings are consistent with osteosarcoma, a type of bone cancer, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur\", \"soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur, a soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase. These findings are consistent with osteosarcoma, a type of bone cancer, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur\", \"soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur, a soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase. These findings are consistent with osteosarcoma, a type of bone cancer, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur\", \"soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur, a soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase. These findings are consistent with osteosarcoma, a type of bone cancer, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a destructive lesion in the distal femur, a soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase. These findings are consistent with osteosarcoma, a type of bone cancer, indicating malignancy.",
      "findings": [
        "destructive lesion in distal femur",
        "soft tissue component",
        "sunburst periosteal reaction",
        "elevated alkaline phosphatase"
      ],
      "fracture_mentioned": null,
      "idx": 37,
      "timestamp": "2026-01-10T18:24:08.432456"
    },
    {
      "sample_idx": 38,
      "input": "05/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 05/03/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with soft tissue involvement and a sunburst periosteal reaction, which are concerning for osteosarcoma. Elevated alkaline phosphatase further supports the possibility of bone tumor. The report also mentions a need for MDT discussion and treatment planning, which is consistent with a suspected malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with soft tissue involvement and a sunburst periosteal reaction, which are concerning for osteosarcoma. Elevated alkaline phosphatase further supports the possibility of bone tumor. The report also mentions a need for MDT discussion and treatment planning, which is consistent with a suspected malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with soft tissue involvement and a sunburst periosteal reaction, which are concerning for osteosarcoma. Elevated alkaline phosphatase further supports the possibility of bone tumor. The report also mentions a need for MDT discussion and treatment planning, which is consistent with a suspected malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with soft tissue involvement and a sunburst periosteal reaction, which are concerning",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a destructive lesion in the distal femur with soft tissue involvement and a sunburst periosteal reaction, which are concerning for osteosarcoma. Elevated alkaline phosphatase further supports the possibility of bone tumor. The report also mentions a need for MDT discussion and treatment planning, which is consistent with a suspected malignancy.",
      "findings": [
        "destructive lesion in distal femur with soft tissue component",
        "sunburst periosteal reaction",
        "elevated alkaline phosphatase"
      ],
      "fracture_mentioned": null,
      "idx": 38,
      "timestamp": "2026-01-10T18:24:08.432471"
    },
    {
      "sample_idx": 39,
      "input": "01/11/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 01/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that post-viral lymphocytosis is present, and atypical lymphocytes are resolving, with confirmation of EBV serology. The report also explicitly states that no malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphoblasts 85% of marrow\", \"B-cell ALL immunophenotype\", \"bone marrow infiltration\"],\n        \"rationale\": \"The report explicitly identifies bone marrow infiltration with lymphoblasts and immunophenotyping consistent with acute lymphoblastic leukemia, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphoblasts 85% of marrow\", \"B-cell ALL immunophenotype\", \"bone marrow infiltration\"],\n        \"rationale\": \"The report explicitly identifies bone marrow infiltration with lymphoblasts and immunophenotyping consistent with acute lymphoblastic leukemia, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphoblasts 85% of marrow\", \"B-cell ALL immunophenotype\", \"bone marrow infiltration\"],\n        \"rationale\": \"The report explicitly identifies bone marrow infiltration with lymphoblasts and immunophenotyping consistent with acute lymphoblastic leukemia, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    ",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that post-viral lymphocytosis is present, and atypical lymphocytes are resolving, with confirmation of EBV serology. The report also explicitly states that no malignancy is identified.",
      "findings": [
        "post-viral lymphocytosis",
        "atypical lymphocytes resolving",
        "monospot positive",
        "EBV serology confirms",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 39,
      "timestamp": "2026-01-10T18:24:08.432483"
    },
    {
      "sample_idx": 40,
      "input": "26/04/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 26/04/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report describes a renal mass with features suggestive of Wilms tumor, including a pseudocapsule and favorable histology. The stage is also specified as II. These findings indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report describes a renal mass with features suggestive of Wilms tumor, including a pseudocapsule and favorable histology. The stage is also specified as II. These findings indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report describes a renal mass with features suggestive of Wilms tumor, including a pseudocapsule and favorable histology. The stage is also specified as II. These findings indicate malignancy.\"\n    }\n}\n```\n```json\n{\n",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a renal mass with features suggestive of Wilms tumor, including a pseudocapsule and favorable histology. The stage is also specified as II. These findings indicate malignancy.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "no vascular invasion",
        "favorable histology on biopsy",
        "stage II"
      ],
      "fracture_mentioned": null,
      "idx": 40,
      "timestamp": "2026-01-10T18:24:08.432494"
    },
    {
      "sample_idx": 41,
      "input": "18/11/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report describes mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and a diagnosis of Classical Hodgkin Lymphoma, nodular sclerosing type. These findings are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"Hodgkin Lymphoma\", \"nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions Hodgkin Lymphoma, nodular sclerosing type, which is a type of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"FDG-avid nodes\"],\n        \"rationale\": \"The report describes FDG-avid nodes, which are a hallmark of malignancy, particularly in the context of Hodgkin Lymphoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bulky anterior mediastinal mass\"],\n        \"rationale\": \"The report describes a bulky anterior mediastinal mass, which is a significant finding suggestive of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\"],\n        \"rationale\": \"The report describes mediastinal lymphadenopathy, which is a common finding in malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"Hodgkin Lymphoma\"],\n        \"rationale\": \"The report mentions Hodgkin Lymphoma, which is a type of",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and a diagnosis of Classical Hodgkin Lymphoma, nodular sclerosing type. These findings are indicative of malignancy.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 41,
      "timestamp": "2026-01-10T18:24:08.432506"
    },
    {
      "sample_idx": 42,
      "input": "20/04/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 20/04/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"The report describes atypical lymphocytes resolving, a positive Monospot test, and confirmed EBV serology. While atypical lymphocytes can sometimes be associated with malignancy, the report explicitly states that no malignancy was identified and that the findings are consistent with a viral infection.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified and that reassurance was provided. This indicates the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"The report describes atypical lymphocytes resolving, a positive Monospot test, and confirmed EBV serology. While atypical lymphocytes can sometimes be associated with malignancy, the report explicitly states that no malignancy was identified and that the findings are consistent with a viral infection.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified and that reassurance was provided. This indicates the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified and that reassurance was provided. This indicates the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    ",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes atypical lymphocytes resolving, a positive Monospot test, and confirmed EBV serology. While atypical lymphocytes can sometimes be associated with malignancy, the report explicitly states that no malignancy was identified and that the findings are consistent with a viral infection.",
      "findings": [
        "Atypical lymphocytes resolving",
        "Monospot positive",
        "EBV serology confirms"
      ],
      "fracture_mentioned": null,
      "idx": 42,
      "timestamp": "2026-01-10T18:24:08.432519"
    },
    {
      "sample_idx": 43,
      "input": "20/01/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 20/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates a normal brain MRI with no evidence of mass lesion, abnormal enhancement, or malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no findings of malignancy\", \"normal appearance\"],\n        \"rationale\": \"The report states that no findings of malignancy were present, and the appearance is normal.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"normal findings\"],\n        \"rationale\": \"The report explicitly states there is no evidence of malignancy and that the findings are normal.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no signs of malignancy\", \"normal appearance\"],\n        \"rationale\": \"The report mentions no signs of malignancy and a normal appearance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"normal\"],\n        \"rationale\": \"The report states there is no evidence of malignancy and the findings are normal.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"normal\"],\n        \"rationale\": \"The report indicates no evidence of malignancy and normal findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"normal\"],\n        \"rationale\": \"The",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report indicates a normal brain MRI with no evidence of mass lesion, abnormal enhancement, or malignancy.",
      "findings": [
        "normal brain MRI",
        "no mass lesion",
        "no abnormal enhancement",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 43,
      "timestamp": "2026-01-10T18:24:08.432528"
    },
    {
      "sample_idx": 44,
      "input": "22/11/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 22/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis with large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report describes bone destruction, a soft tissue mass, and EWSR1 fusion positivity, all of which are indicative of Ewing Sarcoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis with large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report describes bone destruction, a soft tissue mass, and EWSR1 fusion positivity, all of which are indicative of Ewing Sarcoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis with large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report describes bone destruction, a soft tissue mass, and EWSR1 fusion positivity, all of which are indicative of Ewing Sarcoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis with large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report describes bone destruction, a soft tissue mass, and EWSR1 fusion positivity, all of which are indicative of Ewing Sarcoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis with large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes bone destruction, a soft tissue mass, and EWSR1 fusion positivity, all of which are indicative of Ewing Sarcoma.",
      "findings": [
        "permeative bone destruction in left femoral diaphysis with large soft tissue mass",
        "onion-skin periosteal reaction",
        "EWSR1 fusion positive"
      ],
      "fracture_mentioned": null,
      "idx": 44,
      "timestamp": "2026-01-10T18:24:08.432539"
    },
    {
      "sample_idx": 45,
      "input": "06/05/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 06/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes a normal brain MRI without any abnormalities, mass lesions, or evidence of malignancy. Reassurance was provided.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no abnormal findings\", \"no evidence of malignancy\"],\n        \"rationale\": \"The report indicates no abnormal findings and no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal appearance\", \"no evidence of malignancy\"],\n        \"rationale\": \"The report describes a normal appearance and no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal\", \"no evidence of malignancy\"],\n        \"rationale\": \"The report indicates a normal finding and no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal\", \"no evidence of malignancy\"],\n        \"rationale\": \"The report indicates a normal finding and no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal\", \"no evidence of malignancy\"],\n        \"rationale\": \"The report indicates a normal finding and no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal\", \"no evidence of malignancy\"],\n        \"rationale\": \"The report indicates a normal finding and no evidence",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes a normal brain MRI without any abnormalities, mass lesions, or evidence of malignancy. Reassurance was provided.",
      "findings": [
        "normal brain MRI",
        "no mass lesion",
        "no abnormal enhancement",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 45,
      "timestamp": "2026-01-10T18:24:08.432550"
    },
    {
      "sample_idx": 46,
      "input": "24/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Physiological splenomegaly for age\", \"No focal lesions\", \"Normal echo texture\", \"Benign finding\", \"No malignancy identified\"],\n        \"rationale\": \"The report states that the splenomegaly is physiological for age and that no focal lesions, normal echo texture, benign finding or malignancy are identified. Therefore, the finding does not indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Physiological splenomegaly for age\", \"No focal lesions\", \"Normal echo texture\", \"Benign finding\", \"No malignancy identified\"],\n        \"rationale\": \"The report states that the splenomegaly is physiological for age and that no focal lesions, normal echo texture, benign finding or malignancy are identified. Therefore, the finding does not indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Physiological splenomegaly for age\", \"No focal lesions\", \"Normal echo texture\", \"Benign finding\", \"No malignancy identified\"],\n        \"rationale\": \"The report states that the splenomegaly is physiological for age and that no focal lesions, normal echo texture, benign finding or malignancy are identified. Therefore, the finding does not indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Physiological splenomegaly for age\", \"No focal lesions\", \"Normal echo texture\", \"Benign finding\", \"No malignancy identified\"],\n        \"rationale\": \"The report states that the splenomegaly is physiological for age and that no focal lesions, normal echo texture, benign finding or malignancy are identified. Therefore, the finding does not indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Physiological splenomegaly for age\",",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report states that the splenomegaly is physiological for age and that no focal lesions, normal echo texture, benign finding or malignancy are identified. Therefore, the finding does not indicate malignancy.",
      "findings": [
        "Physiological splenomegaly for age",
        "No focal lesions",
        "Normal echo texture",
        "Benign finding",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 46,
      "timestamp": "2026-01-10T18:24:08.432562"
    },
    {
      "sample_idx": 47,
      "input": "01/02/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 01/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign finding. There are no atypical features or malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign finding. There are no atypical features or malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign finding. There are no atypical features or malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign finding. There are no atypical features or malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign finding. There are no atypical features or malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes reactive lymphadenopathy, which is a benign finding. There are no atypical features or malignancy identified.",
      "findings": [
        "reactive lymphadenopathy",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 47,
      "timestamp": "2026-01-10T18:24:08.432572"
    },
    {
      "sample_idx": 48,
      "input": "03/10/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 03/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur\", \"soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with a soft tissue component and sunburst periosteal reaction, strongly suggestive of osteosarcoma. Elevated alkaline phosphatase also supports this diagnosis. The clinical context of suspected osteosarcoma further strengthens this conclusion.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur\", \"soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with a soft tissue component and sunburst periosteal reaction, strongly suggestive of osteosarcoma. Elevated alkaline phosphatase also supports this diagnosis. The clinical context of suspected osteosarcoma further strengthens this conclusion.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur\", \"soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with a soft tissue component and sunburst periosteal reaction, strongly suggestive of osteosarcoma. Elevated alkaline phosphatase also supports this diagnosis. The clinical context of suspected osteosarcoma further strengthens this conclusion.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur\", \"soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with a soft tissue component and sunburst periosteal reaction, strongly suggestive of osteosarcoma. Elevated alkaline phosphatase also supports this diagnosis. The clinical context of suspected osteosarcoma further strengthens this conclusion.\"\n    }\n}\n```\n```json",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a destructive lesion in the distal femur with a soft tissue component and sunburst periosteal reaction, strongly suggestive of osteosarcoma. Elevated alkaline phosphatase also supports this diagnosis. The clinical context of suspected osteosarcoma further strengthens this conclusion.",
      "findings": [
        "destructive lesion in distal femur",
        "soft tissue component",
        "sunburst periosteal reaction",
        "elevated alkaline phosphatase"
      ],
      "fracture_mentioned": null,
      "idx": 48,
      "timestamp": "2026-01-10T18:24:08.432586"
    },
    {
      "sample_idx": 49,
      "input": "05/08/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 05/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign finding. It explicitly states that no atypical features or malignancy are identified. Therefore, no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphoblasts 85% of marrow\", \"B-cell ALL immunophenotype\", \"bone marrow infiltration\"],\n        \"rationale\": \"The report explicitly identifies bone marrow infiltration with lymphoblasts and immunophenotyping consistent with acute lymphoblastic leukemia, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"lymphoblasts 85% of marrow\", \"B-cell ALL immunophenotype\", \"bone marrow infiltration\"],\n        \"rationale\": \"The report explicitly identifies bone marrow infiltration with lymphoblasts and immunophenotyping consistent with acute lymphoblastic leukemia, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign finding. It explicitly states that no atypical features or malignancy are identified. Therefore, no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes reactive lymphadenopathy, which is a benign finding. It explicitly states that no atypical features or malignancy are identified. Therefore, no malignancy is present.",
      "findings": [
        "reactive lymphadenopathy",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 49,
      "timestamp": "2026-01-10T18:24:08.432597"
    },
    {
      "sample_idx": 50,
      "input": "02/05/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report describes a normal chest radiograph, clear lung fields, no mediastinal mass, normal heart size, and explicitly states that no malignancy was identified. Reassurance was provided. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report describes a normal chest radiograph, clear lung fields, no mediastinal mass, normal heart size, and explicitly states that no malignancy was identified. Reassurance was provided. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report describes a normal chest radiograph, clear lung fields, no mediastinal mass, normal heart size, and explicitly states that no malignancy was identified. Reassurance was provided. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report describes a normal chest radiograph, clear lung fields, no mediastinal mass, normal heart size, and explicitly states that no malignancy was identified. Reassurance was provided. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes a normal chest radiograph, clear lung fields, no mediastinal mass, normal heart size, and explicitly states that no malignancy was identified. Reassurance was provided. Therefore, there is no evidence of malignancy.",
      "findings": [
        "normal chest radiograph",
        "clear lung fields",
        "no mediastinal mass",
        "heart size normal",
        "no malignancy identified",
        "reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 50,
      "timestamp": "2026-01-10T18:24:08.432609"
    },
    {
      "sample_idx": 51,
      "input": "26/07/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 26/07/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lipoma\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes a lipoma, and explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lipoma\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes a lipoma, and explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lipoma\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes a lipoma, and explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lipoma\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes a lipoma, and explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lipoma\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes a lipoma, and explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lipoma\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes a lipoma, and explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lipoma\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes a lipoma, and explicitly",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes a lipoma, and explicitly states that no malignancy was identified.",
      "findings": [
        "lipoma",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 51,
      "timestamp": "2026-01-10T18:24:08.432617"
    },
    {
      "sample_idx": 52,
      "input": "25/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Bone pain. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 25/03/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report describes a left renal mass with characteristics suggestive of Wilms Tumor, including a pseudocapsule, absence of vascular invasion, and favorable histology. The stage II classification further supports the diagnosis of Wilms Tumor, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report describes a left renal mass with characteristics suggestive of Wilms Tumor, including a pseudocapsule, absence of vascular invasion, and favorable histology. The stage II classification further supports the diagnosis of Wilms Tumor, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report describes a left renal mass with characteristics suggestive of Wilms Tumor, including a pseudocapsule, absence of vascular invasion, and favorable histology. The stage II classification further supports the diagnosis of Wilms Tumor, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report describes a left renal mass with characteristics suggestive of Wilms Tumor, including a pseudocapsule, absence of vascular invasion, and favorable histology. The stage II classification further supports the diagnosis of Wilms Tumor, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malign",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a left renal mass with characteristics suggestive of Wilms Tumor, including a pseudocapsule, absence of vascular invasion, and favorable histology. The stage II classification further supports the diagnosis of Wilms Tumor, indicating malignancy.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "no vascular invasion",
        "favorable histology on biopsy",
        "stage II"
      ],
      "fracture_mentioned": null,
      "idx": 52,
      "timestamp": "2026-01-10T18:24:08.432631"
    },
    {
      "sample_idx": 53,
      "input": "05/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 05/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates reactive lymphadenopathy, which is a non-cancerous condition. The absence of atypical features and the explicit statement of no malignancy confirm that the findings do not represent malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates reactive lymphadenopathy, which is a non-cancerous condition. The absence of atypical features and the explicit statement of no malignancy confirm that the findings do not represent malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates reactive lymphadenopathy, which is a non-cancerous condition. The absence of atypical features and the explicit statement of no malignancy confirm that the findings do not represent malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates reactive lymphadenopathy, which is a non-cancerous condition. The absence of atypical features and the explicit statement of no malignancy confirm that the findings do not represent malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates reactive lymphadenopathy, which is a non-cancerous condition. The absence of atypical features and the explicit statement of no malignancy confirm that the findings do not represent malignancy.\"",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report indicates reactive lymphadenopathy, which is a non-cancerous condition. The absence of atypical features and the explicit statement of no malignancy confirm that the findings do not represent malignancy.",
      "findings": [
        "reactive lymphadenopathy",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 53,
      "timestamp": "2026-01-10T18:24:08.432642"
    },
    {
      "sample_idx": 54,
      "input": "23/03/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 23/03/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous hepatic mass, elevated AFP, a specific histology subtype, and a stage indicating a malignancy (Hepatoblastoma). The report explicitly mentions Hepatoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous hepatic mass, elevated AFP, a specific histology subtype, and a stage indicating a malignancy (Hepatoblastoma). The report explicitly mentions Hepatoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous hepatic mass, elevated AFP, a specific histology subtype, and a stage indicating a malignancy (Hepatoblastoma). The report explicitly mentions Hepatoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous hepatic mass, elevated AFP, a specific histology subtype, and a stage indicating a malignancy (Hepatoblastoma). The report explicitly mentions Hepatoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a large heterogeneous hepatic mass, elevated AFP, a specific histology subtype, and a stage indicating a malignancy (Hepatoblastoma). The report explicitly mentions Hepatoblastoma.",
      "findings": [
        "large heterogeneous hepatic mass",
        "elevated AFP",
        "Fetal histology subtype",
        "PRETEXT stage II"
      ],
      "fracture_mentioned": null,
      "idx": 54,
      "timestamp": "2026-01-10T18:24:08.432653"
    },
    {
      "sample_idx": 55,
      "input": "31/08/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 31/08/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the chest radiograph is normal and no malignancy is identified. No abnormal findings indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the chest radiograph is normal and no malignancy is identified. No abnormal findings indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the chest radiograph is normal and no malignancy is identified. No abnormal findings indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the chest radiograph is normal and no malignancy is identified. No abnormal findings indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the chest radiograph is normal and no malignancy is identified. No abnormal findings indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report states that the chest radiograph is normal and no malignancy is identified. No abnormal findings indicating malignancy.",
      "findings": [
        "normal chest radiograph",
        "clear lung fields",
        "no mediastinal mass",
        "heart size normal",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 55,
      "timestamp": "2026-01-10T18:24:08.432664"
    },
    {
      "sample_idx": 56,
      "input": "26/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 26/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign finding. The report explicitly states that no atypical features or malignancy were identified. Therefore, malignancy is not present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign finding. The report explicitly states that no atypical features or malignancy were identified. Therefore, malignancy is not present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign finding. The report explicitly states that no atypical features or malignancy were identified. Therefore, malignancy is not present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign finding. The report explicitly states that no atypical features or malignancy were identified. Therefore, malignancy is not present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign finding. The report explicitly states that no atypical features or malignancy were identified. Therefore, malignancy is not present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\":",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes reactive lymphadenopathy, which is a benign finding. The report explicitly states that no atypical features or malignancy were identified. Therefore, malignancy is not present.",
      "findings": [
        "reactive lymphadenopathy",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 56,
      "timestamp": "2026-01-10T18:24:08.432675"
    },
    {
      "sample_idx": 57,
      "input": "24/11/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"The report explicitly mentions a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG levels, and the presence of yolk sac tumor elements. These findings are highly suggestive of a Germ Cell Tumor, a type of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"The report explicitly mentions a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG levels, and the presence of yolk sac tumor elements. These findings are highly suggestive of a Germ Cell Tumor, a type of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"The report explicitly mentions a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG levels, and the presence of yolk sac tumor elements. These findings are highly suggestive of a Germ Cell Tumor, a type of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"The report explicitly mentions a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG levels",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly mentions a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG levels, and the presence of yolk sac tumor elements. These findings are highly suggestive of a Germ Cell Tumor, a type of malignancy.",
      "findings": [
        "sacrococcygeal mass with mixed solid and cystic components",
        "elevated AFP and beta-hCG",
        "yolk sac tumor elements present"
      ],
      "fracture_mentioned": null,
      "idx": 57,
      "timestamp": "2026-01-10T18:24:08.432687"
    },
    {
      "sample_idx": 58,
      "input": "01/01/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 01/01/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass\", \"mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements, all of which are indicative of a germ cell tumor, specifically a Yolk Sac Tumor. These findings strongly suggest malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass\", \"mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements, all of which are indicative of a germ cell tumor, specifically a Yolk Sac Tumor. These findings strongly suggest malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass\", \"mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements, all of which are indicative of a germ cell tumor, specifically a Yolk Sac Tumor. These findings strongly suggest malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass\", \"mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"The report describes a sac",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements, all of which are indicative of a germ cell tumor, specifically a Yolk Sac Tumor. These findings strongly suggest malignancy.",
      "findings": [
        "sacrococcygeal mass",
        "mixed solid and cystic components",
        "elevated AFP and beta-hCG",
        "yolk sac tumor elements present"
      ],
      "fracture_mentioned": null,
      "idx": 58,
      "timestamp": "2026-01-10T18:24:08.432700"
    },
    {
      "sample_idx": 59,
      "input": "16/06/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/06/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\", \"parameningeal mass with intracranial extension\"],\n        \"rationale\": \"The report explicitly states 'embryonal rhabdomyosarcoma' and describes a 'parameningeal mass with intracranial extension', indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\"],\n        \"rationale\": \"The report states 'embryonal rhabdomyosarcoma', indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\"],\n        \"rationale\": \"The report explicitly mentions 'parameningeal mass with intracranial extension', which indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\"],\n        \"rationale\": \"The report explicitly identifies 'embryonal rhabdomyosarcoma', which is a type of cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\"],\n        \"rationale\": \"The report indicates the presence of 'embryonal rhabdomyosarcoma', which is a malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\"],\n        \"rationale\": \"The report explicitly mentions 'embryonal rhabdomyosarcoma', which is a cancerous tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malign",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly states 'embryonal rhabdomyosarcoma' and describes a 'parameningeal mass with intracranial extension', indicating malignancy.",
      "findings": [
        "embryonal rhabdomyosarcoma",
        "parameningeal mass with intracranial extension"
      ],
      "fracture_mentioned": null,
      "idx": 59,
      "timestamp": "2026-01-10T18:24:08.432710"
    },
    {
      "sample_idx": 60,
      "input": "08/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 08/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no mass lesion, abnormal enhancement, or malignancy were identified on the CT scan, and the brain MRI was normal. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no mass lesion, abnormal enhancement, or malignancy were identified on the CT scan, and the brain MRI was normal. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no mass lesion, abnormal enhancement, or malignancy were identified on the CT scan, and the brain MRI was normal. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no mass lesion, abnormal enhancement, or malignancy were identified on the CT scan, and the brain MRI was normal. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no mass lesion, abnormal enhancement, or malignancy were identified on the CT scan, and the brain MRI was normal. No evidence of malignancy.\"\n    }\n}",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that no mass lesion, abnormal enhancement, or malignancy were identified on the CT scan, and the brain MRI was normal. No evidence of malignancy.",
      "findings": [
        "normal brain MRI",
        "no mass lesion",
        "no abnormal enhancement",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 60,
      "timestamp": "2026-01-10T18:24:08.432721"
    },
    {
      "sample_idx": 61,
      "input": "09/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 09/07/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"No malignancy identified\"],\n        \"rationale\": \"The report describes post-viral lymphocytosis and atypical lymphocytes resolving, confirmed by EBV serology. No malignancy is identified, and reassurance is provided.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"No malignancy identified\"],\n        \"rationale\": \"The report describes post-viral lymphocytosis and atypical lymphocytes resolving, confirmed by EBV serology. No malignancy is identified, and reassurance is provided.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"No malignancy identified\"],\n        \"rationale\": \"The report describes post-viral lymphocytosis and atypical lymphocytes resolving, confirmed by EBV serology. No malignancy is identified, and reassurance is provided.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"No malignancy identified\"],\n        \"rationale\": \"The report describes post-viral lymphocytosis and atypical lymphocytes resolving, confirmed by EBV serology. No malignancy is identified, and reassurance is provided.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\",",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes post-viral lymphocytosis and atypical lymphocytes resolving, confirmed by EBV serology. No malignancy is identified, and reassurance is provided.",
      "findings": [
        "post-viral lymphocytosis",
        "atypical lymphocytes resolving",
        "monospot positive",
        "EBV serology confirms",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 61,
      "timestamp": "2026-01-10T18:24:08.432732"
    },
    {
      "sample_idx": 62,
      "input": "08/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 08/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that reactive lymphadenopathy was found, with no atypical features and no malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy, which is not indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy, which is not indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy, which is not indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy, which is not indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy, which is not indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy, which is not indicative of malignancy.\"\n",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that reactive lymphadenopathy was found, with no atypical features and no malignancy identified.",
      "findings": [
        "reactive lymphadenopathy",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 62,
      "timestamp": "2026-01-10T18:24:08.432742"
    },
    {
      "sample_idx": 63,
      "input": "04/12/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 04/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"blood counts normalized\", \"no organomegaly\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates a resolved febrile illness and normalized blood counts, suggesting the patient is in good condition. It explicitly states that no malignancy was identified, ruling out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"blood counts normalized\", \"no organomegaly\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates a resolved febrile illness and normalized blood counts, suggesting the patient is in good condition. It explicitly states that no malignancy was identified, ruling out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"blood counts normalized\", \"no organomegaly\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates a resolved febrile illness and normalized blood counts, suggesting the patient is in good condition. It explicitly states that no malignancy was identified, ruling out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"blood counts normalized\", \"no organomegaly\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates a resolved febrile illness and normalized blood counts, suggesting the patient is in good condition. It explicitly states that no malignancy was identified, ruling out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"blood counts normalized\", \"no organomegaly\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates a resolved febrile illness and normalized blood counts, suggesting the patient is in good condition. It explicitly states",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report indicates a resolved febrile illness and normalized blood counts, suggesting the patient is in good condition. It explicitly states that no malignancy was identified, ruling out malignancy.",
      "findings": [
        "resolved febrile illness",
        "blood counts normalized",
        "no organomegaly",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 63,
      "timestamp": "2026-01-10T18:24:08.432753"
    },
    {
      "sample_idx": 64,
      "input": "29/09/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 29/09/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy, which is a benign finding. The report also states that no atypical features are present and no malignancy is identified. Therefore, malignancy is ruled out.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly mentions lymphadenopathy. The report also states that no atypical features are present and no malignancy is identified. Therefore, malignancy is ruled out.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly mentions lymphadenopathy. The report also states that no atypical features are present and no malignancy is identified. Therefore, malignancy is ruled out.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly mentions lymphadenopathy. The report also states that no atypical features are present and no malignancy is identified. Therefore, malignancy is ruled out.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly mentions lymphadenopathy. The report also states that no atypical features are present and no malignancy is identified. Therefore, malignancy is ruled out.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly mentions reactive lymphadenopathy, which is a benign finding. The report also states that no atypical features are present and no malignancy is identified. Therefore, malignancy is ruled out.",
      "findings": [
        "reactive lymphadenopathy",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 64,
      "timestamp": "2026-01-10T18:24:08.432764"
    },
    {
      "sample_idx": 65,
      "input": "09/06/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 09/06/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report describes an intraocular mass with calcifications, bilateral disease, positive family history, and a detected RB1 germline mutation, strongly suggesting retinoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report describes an intraocular mass with calcifications, bilateral disease, positive family history, and a detected RB1 germline mutation, strongly suggesting retinoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report describes an intraocular mass with calcifications, bilateral disease, positive family history, and a detected RB1 germline mutation, strongly suggesting retinoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report describes an intraocular mass with calcifications, bilateral disease, positive family history, and a detected RB1 germline mutation, strongly suggesting retinoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report describes an intraocular",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes an intraocular mass with calcifications, bilateral disease, positive family history, and a detected RB1 germline mutation, strongly suggesting retinoblastoma.",
      "findings": [
        "intraocular mass with calcifications",
        "bilateral disease",
        "family history positive",
        "RB1 germline mutation detected"
      ],
      "fracture_mentioned": null,
      "idx": 65,
      "timestamp": "2026-01-10T18:24:08.432776"
    },
    {
      "sample_idx": 66,
      "input": "16/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are indicative of Neuroblastoma. The stage of the disease is also specified as Stage III, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are indicative of Neuroblastoma. The stage of the disease is also specified as Stage III, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are indicative of Neuroblastoma. The stage of the disease is also specified as Stage III, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are indicative of Neuroblastoma. The stage of the disease is also specified as Stage III, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are indicative of Neuroblastoma. The stage of the disease is also specified as Stage III, confirming malignancy.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "elevated urinary catecholamines",
        "Stage III disease"
      ],
      "fracture_mentioned": null,
      "idx": 66,
      "timestamp": "2026-01-10T18:24:08.432789"
    },
    {
      "sample_idx": 67,
      "input": "21/03/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates normal blood counts, the absence of blast cells, adequate platelets, and normal hemoglobin, with no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates normal blood counts, the absence of blast cells, adequate platelets, and normal hemoglobin, with no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates normal blood counts, the absence of blast cells, adequate platelets, and normal hemoglobin, with no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates normal blood counts, the absence of blast cells, adequate platelets, and normal hemoglobin, with no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates normal blood counts, the absence",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report indicates normal blood counts, the absence of blast cells, adequate platelets, and normal hemoglobin, with no evidence of malignancy.",
      "findings": [
        "normal CBC with age-appropriate values",
        "no blast cells",
        "platelets adequate",
        "hemoglobin within normal limits",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 67,
      "timestamp": "2026-01-10T18:24:08.432800"
    },
    {
      "sample_idx": 68,
      "input": "27/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\", \"parameningeal mass with intracranial extension\"],\n        \"rationale\": \"The report explicitly mentions embryonal rhabdomyosarcoma, a type of cancer, along with a parameningeal mass with intracranial extension. This strongly indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\"],\n        \"rationale\": \"The report explicitly mentions embryonal rhabdomyosarcoma, a type of cancer. This strongly indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\"],\n        \"rationale\": \"The report explicitly mentions parameningeal mass with intracranial extension, indicating a malignant process.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\"],\n        \"rationale\": \"The report explicitly mentions embryonal rhabdomyosarcoma, a type of cancer. This strongly indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\"],\n        \"rationale\": \"The report explicitly mentions embryonal rhabdomyosarcoma, a type of cancer. This strongly indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\"],\n        \"rationale\": \"The report explicitly mentions embryonal rhabdomyosarcoma, a type of cancer. This strongly indicates malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly mentions embryonal rhabdomyosarcoma, a type of cancer, along with a parameningeal mass with intracranial extension. This strongly indicates malignancy.",
      "findings": [
        "embryonal rhabdomyosarcoma",
        "parameningeal mass with intracranial extension"
      ],
      "fracture_mentioned": null,
      "idx": 68,
      "timestamp": "2026-01-10T18:24:08.432811"
    },
    {
      "sample_idx": 69,
      "input": "16/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 16/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified on the chest radiograph and other imaging, providing reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified on the chest radiograph and other imaging, providing reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified on the chest radiograph and other imaging, providing reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified on the chest radiograph and other imaging, providing reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified on the chest radiograph and other imaging, providing reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\":",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that no malignancy was identified on the chest radiograph and other imaging, providing reassurance.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 69,
      "timestamp": "2026-01-10T18:24:08.432821"
    },
    {
      "sample_idx": 70,
      "input": "29/11/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 29/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report explicitly mentions an intraocular mass with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, which are all indicative of retinoblastoma, a type of eye cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report explicitly mentions an intraocular mass with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, which are all indicative of retinoblastoma, a type of eye cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report explicitly mentions an intraocular mass with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, which are all indicative of retinoblastoma, a type of eye cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report explicitly mentions an intraocular mass with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, which are all indicative of retinoblastoma, a type of eye cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly mentions an intraocular mass with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, which are all indicative of retinoblastoma, a type of eye cancer.",
      "findings": [
        "intraocular mass with calcifications",
        "bilateral disease",
        "family history positive",
        "RB1 germline mutation detected"
      ],
      "fracture_mentioned": null,
      "idx": 70,
      "timestamp": "2026-01-10T18:24:08.432834"
    },
    {
      "sample_idx": 71,
      "input": "11/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 11/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy with bulky anterior mediastinal mass\", \"PET-CT showing FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly describes mediastinal lymphadenopathy and FDG-avid nodes, along with a diagnosis of Classical Hodgkin Lymphoma, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"Hodgkin Lymphoma\", \"nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions Hodgkin Lymphoma with nodular sclerosing type, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"Hodgkin Lymphoma\", \"nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions Hodgkin Lymphoma with nodular sclerosing type, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"Hodgkin Lymphoma\", \"nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions Hodgkin Lymphoma with nodular sclerosing type, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"Hodgkin Lymphoma\", \"nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions Hodgkin Lymphoma with nodular sclerosing type, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"Hodgkin Lymphoma\", \"nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions Hodgkin Lymphoma with nodular sclerosing type,",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly describes mediastinal lymphadenopathy and FDG-avid nodes, along with a diagnosis of Classical Hodgkin Lymphoma, confirming malignancy.",
      "findings": [
        "mediastinal lymphadenopathy with bulky anterior mediastinal mass",
        "PET-CT showing FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 71,
      "timestamp": "2026-01-10T18:24:08.432845"
    },
    {
      "sample_idx": 72,
      "input": "13/09/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 13/09/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"The report explicitly mentions a parameningeal mass with intracranial extension, confirming the diagnosis of embryonal rhabdomyosarcoma, which is a type of cancer. The negative PAX-FOXO1 fusion status is also relevant to the diagnosis and treatment planning.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"The report explicitly mentions a parameningeal mass with intracranial extension, confirming the diagnosis of embryonal rhabdomyosarcoma, which is a type of cancer. The negative PAX-FOXO1 fusion status is also relevant to the diagnosis and treatment planning.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"The report explicitly mentions a parameningeal mass with intracranial extension, confirming the diagnosis of embryonal rhabdomyosarcoma, which is a type of cancer. The negative PAX-FOXO1 fusion status is also relevant to the diagnosis and treatment planning.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"The report explicitly mentions a parameningeal mass with intracranial extension, confirming the diagnosis of embryonal rhabdomyosarcoma, which is a type of cancer. The negative PAX-FO",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly mentions a parameningeal mass with intracranial extension, confirming the diagnosis of embryonal rhabdomyosarcoma, which is a type of cancer. The negative PAX-FOXO1 fusion status is also relevant to the diagnosis and treatment planning.",
      "findings": [
        "parameningeal mass with intracranial extension",
        "embryonal rhabdomyosarcoma on biopsy",
        "PAX-FOXO1 fusion negative"
      ],
      "fracture_mentioned": null,
      "idx": 72,
      "timestamp": "2026-01-10T18:24:08.432857"
    },
    {
      "sample_idx": 73,
      "input": "03/12/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 03/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly for age\", \"no focal lesions\", \"normal echo texture\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the spleen is enlarged due to age and that no focal lesions or malignancy were found.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly for age\", \"no focal lesions\", \"normal echo texture\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the spleen is enlarged due to age and that no focal lesions or malignancy were found.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly for age\", \"no focal lesions\", \"normal echo texture\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the spleen is enlarged due to age and that no focal lesions or malignancy were found.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly for age\", \"no focal lesions\", \"normal echo texture\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the spleen is enlarged due to age and that no focal lesions or malignancy were found.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly for age\", \"no focal lesions\", \"normal echo texture\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the spleen is enlarged due to age and that no focal lesions or malignancy were found.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly for age",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report states that the spleen is enlarged due to age and that no focal lesions or malignancy were found.",
      "findings": [
        "physiological splenomegaly for age",
        "no focal lesions",
        "normal echo texture",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 73,
      "timestamp": "2026-01-10T18:24:08.432885"
    },
    {
      "sample_idx": 74,
      "input": "11/10/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 11/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction\", \"large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report describes findings consistent with Ewing Sarcoma, including bone destruction, soft tissue mass, periosteal reaction, and EWSR1 fusion positivity, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction\", \"large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report describes findings consistent with Ewing Sarcoma, including bone destruction, soft tissue mass, periosteal reaction, and EWSR1 fusion positivity, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction\", \"large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report describes findings consistent with Ewing Sarcoma, including bone destruction, soft tissue mass, periosteal reaction, and EWSR1 fusion positivity, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction\", \"large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report describes findings consistent with Ewing Sarcoma, including bone destruction, soft tissue mass, periosteal reaction, and EWSR1 fusion positivity, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction\", \"large soft tissue mass",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes findings consistent with Ewing Sarcoma, including bone destruction, soft tissue mass, periosteal reaction, and EWSR1 fusion positivity, all of which are indicative of malignancy.",
      "findings": [
        "permeative bone destruction",
        "large soft tissue mass",
        "onion-skin periosteal reaction",
        "EWSR1 fusion positive"
      ],
      "fracture_mentioned": null,
      "idx": 74,
      "timestamp": "2026-01-10T18:24:08.432897"
    },
    {
      "sample_idx": 75,
      "input": "28/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 28/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"The report identifies reactive lymphadenopathy secondary to viral infection, with decreasing node size and no atypical features. The final statement explicitly indicates that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"The report identifies reactive lymphadenopathy secondary to viral infection, with decreasing node size and no atypical features. The final statement explicitly indicates that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"The report identifies reactive lymphadenopathy secondary to viral infection, with decreasing node size and no atypical features. The final statement explicitly indicates that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"The report identifies reactive lymphadenopathy secondary to viral infection, with decreasing node size and no atypical features. The final statement explicitly indicates that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"ration",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report identifies reactive lymphadenopathy secondary to viral infection, with decreasing node size and no atypical features. The final statement explicitly indicates that no malignancy was identified.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up",
        "No atypical features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 75,
      "timestamp": "2026-01-10T18:24:08.432909"
    },
    {
      "sample_idx": 76,
      "input": "02/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report describes normal CBC parameters, the absence of blast cells, and explicitly states that no malignancy is identified. The doctor provides reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates normal blood counts and specifically states no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states no malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states no malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states no malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"no blast cells\", \"platelets adequate\", \"hemoglobin",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes normal CBC parameters, the absence of blast cells, and explicitly states that no malignancy is identified. The doctor provides reassurance.",
      "findings": [
        "normal CBC with age-appropriate values",
        "no blast cells",
        "platelets adequate",
        "hemoglobin within normal limits",
        "no malignancy identified",
        "reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 76,
      "timestamp": "2026-01-10T18:24:08.432921"
    },
    {
      "sample_idx": 77,
      "input": "06/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 06/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes a healing fracture with normal findings and explicitly states that no malignancy was identified. The report also confirms reassurance was provided.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that there are no pathological features and no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates that there are no pathological features and no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly mentions no pathological features and no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates that there are no pathological features and no malignancy",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes a healing fracture with normal findings and explicitly states that no malignancy was identified. The report also confirms reassurance was provided.",
      "findings": [
        "healing fracture",
        "normal bone density",
        "no pathological features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 77,
      "timestamp": "2026-01-10T18:24:08.432932"
    },
    {
      "sample_idx": 78,
      "input": "27/02/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"The report explicitly states bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells and immunophenotyping consistent with B-cell ALL, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"The report explicitly states bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells and immunophenotyping consistent with B-cell ALL, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"The report explicitly states bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells and immunophenotyping consistent with B-cell ALL, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"The report explicitly states bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells and immunophenotyping consistent with B-cell ALL, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly states bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells and immunophenotyping consistent with B-cell ALL, confirming malignancy.",
      "findings": [
        "bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells",
        "Immunophenotyping consistent with B-cell ALL"
      ],
      "fracture_mentioned": null,
      "idx": 78,
      "timestamp": "2026-01-10T18:24:08.432944"
    },
    {
      "sample_idx": 79,
      "input": "17/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 17/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Post-viral lymphocytosis\", \"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\", \"No malignancy identified\"],\n        \"rationale\": \"The report notes post-viral lymphocytosis with atypical lymphocytes that are resolving, confirmed by Monospot and EBV serology. It explicitly states that no malignancy is identified. Therefore, the presence of atypical lymphocytes and the confirmation of the viral etiology, combined with the explicit statement of no malignancy, indicates abnormal findings, but not malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Post-viral lymphocytosis\", \"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\", \"No malignancy identified\"],\n        \"rationale\": \"The report notes post-viral lymphocytosis with atypical lymphocytes that are resolving, confirmed by Monospot and EBV serology. It explicitly states that no malignancy is identified. Therefore, the presence of atypical lymphocytes and the confirmation of the viral etiology, combined with the explicit statement of no malignancy, indicates abnormal findings, but not malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Post-viral lymphocytosis\", \"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\", \"No malignancy identified\"],\n        \"rationale\": \"The report notes post-viral lymphocytosis with atypical lymphocytes that are resolving, confirmed by Monospot and EBV serology. It explicitly states that no malignancy is identified. Therefore, the presence of atypical lymphocytes and the confirmation of the viral etiology, combined with the explicit statement of no malignancy, indicates abnormal findings, but not malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Post-viral lymphocytosis\", \"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\", \"No malignancy identified\"],\n        ",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report notes post-viral lymphocytosis with atypical lymphocytes that are resolving, confirmed by Monospot and EBV serology. It explicitly states that no malignancy is identified. Therefore, the presence of atypical lymphocytes and the confirmation of the viral etiology, combined with the explicit statement of no malignancy, indicates abnormal findings, but not malignancy.",
      "findings": [
        "Post-viral lymphocytosis",
        "Atypical lymphocytes resolving",
        "Monospot positive",
        "EBV serology confirms",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 79,
      "timestamp": "2026-01-10T18:24:08.432959"
    },
    {
      "sample_idx": 80,
      "input": "18/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 18/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there is no malignancy identified. Physiological splenomegaly and normal echo texture are benign findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there is no malignancy identified. Physiological splenomegaly and normal echo texture are benign findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there is no malignancy identified. Physiological splenomegaly and normal echo texture are benign findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there is no malignancy identified. Physiological splenomegaly and normal echo texture are benign findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there is no malignancy identified. Physiological splenomegaly and normal echo texture are benign findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that there is no malignancy identified. Physiological splenomegaly and normal echo texture are benign findings.",
      "findings": [
        "physiological splenomegaly",
        "no focal lesions",
        "normal echo texture",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 80,
      "timestamp": "2026-01-10T18:24:08.432969"
    },
    {
      "sample_idx": 81,
      "input": "11/06/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 11/06/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"benign soft tissue mass - lipoma\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states the finding of a benign lipoma and confirms the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lipoma\", \"no malignancy\"],\n        \"rationale\": \"The report identifies a lipoma and states that no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lipoma\", \"no malignancy\"],\n        \"rationale\": \"The report identifies a lipoma and states that no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lipoma\", \"no malignancy\"],\n        \"rationale\": \"The report identifies a lipoma and states that no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lipoma\", \"no malignancy\"],\n        \"rationale\": \"The report identifies a lipoma and states that no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lipoma\", \"no malignancy\"],\n        \"rationale\": \"The report identifies a lipoma and states that no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lipoma\", \"no malignancy\"],\n        \"rationale\": \"The report identifies a lipoma and states that no malignancy is present.\"\n    }",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states the finding of a benign lipoma and confirms the absence of malignancy.",
      "findings": [
        "benign soft tissue mass - lipoma",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 81,
      "timestamp": "2026-01-10T18:24:08.432978"
    },
    {
      "sample_idx": 82,
      "input": "27/12/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 27/12/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"No vascular invasion\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report describes a left renal mass, which is suggestive of Wilms tumor. The presence of a pseudocapsule, favorable histology, and Stage II classification strongly indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"No vascular invasion\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report describes a left renal mass, which is suggestive of Wilms tumor. The presence of a pseudocapsule, favorable histology, and Stage II classification strongly indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"No vascular invasion\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report describes a left renal mass, which is suggestive of Wilms tumor. The presence of a pseudocapsule, favorable histology, and Stage II classification strongly indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"No vascular invasion\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report describes a left renal mass, which is suggestive of Wilms tumor. The presence of a pseudocapsule, favorable histology, and Stage II classification strongly indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"No vascular invasion\", \"Favorable histology on biopsy\", \"Stage II\"],",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a left renal mass, which is suggestive of Wilms tumor. The presence of a pseudocapsule, favorable histology, and Stage II classification strongly indicate malignancy.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "No vascular invasion",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 82,
      "timestamp": "2026-01-10T18:24:08.432990"
    },
    {
      "sample_idx": 83,
      "input": "05/11/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 05/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase. These findings are suggestive of osteosarcoma, a type of bone cancer, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase. These findings are suggestive of osteosarcoma, a type of bone cancer, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase. These findings are suggestive of osteosarcoma, a type of bone cancer, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase. These findings are suggestive of osteosarcoma, a type of bone cancer, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        ",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a destructive lesion in the distal femur with soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase. These findings are suggestive of osteosarcoma, a type of bone cancer, indicating malignancy.",
      "findings": [
        "destructive lesion in distal femur with soft tissue component",
        "sunburst periosteal reaction",
        "elevated alkaline phosphatase"
      ],
      "fracture_mentioned": null,
      "idx": 83,
      "timestamp": "2026-01-10T18:24:08.433002"
    },
    {
      "sample_idx": 84,
      "input": "23/11/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 23/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"no pathological features\", \"normal bone density\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes a healing fracture with normal findings, ruling out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features and no malignancy is identified, thus ruling out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features and no malignancy is identified, thus ruling out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features and no malignancy is identified, thus ruling out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features and no malignancy is identified, thus ruling out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features and no malignancy is identified, thus ruling out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    ",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes a healing fracture with normal findings, ruling out malignancy.",
      "findings": [
        "healing fracture",
        "no pathological features",
        "normal bone density",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 84,
      "timestamp": "2026-01-10T18:24:08.433011"
    },
    {
      "sample_idx": 85,
      "input": "14/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 14/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal and that no malignancy is identified, indicating no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal and that no malignancy is identified, indicating no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal and that no malignancy is identified, indicating no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal and that no malignancy is identified, indicating no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal and that no malignancy is identified, indicating no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that the chest radiograph is normal and that no malignancy is identified, indicating no evidence of malignancy.",
      "findings": [
        "normal chest radiograph",
        "clear lung fields",
        "no mediastinal mass",
        "heart size normal",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 85,
      "timestamp": "2026-01-10T18:24:08.433022"
    },
    {
      "sample_idx": 86,
      "input": "11/06/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 11/06/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large hepatic mass, elevated AFP, a specific histology subtype (Fetal), and a stage (II), all suggestive of hepatoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large hepatic mass, elevated AFP, a specific histology subtype (Fetal), and a stage (II), all suggestive of hepatoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large hepatic mass, elevated AFP, a specific histology subtype (Fetal), and a stage (II), all suggestive of hepatoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large hepatic mass, elevated AFP, a specific histology subtype (Fetal), and a stage (II), all suggestive of hepatoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large hepatic mass, elevated AFP, a specific histology subtype (Fetal), and a stage (II),",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a large hepatic mass, elevated AFP, a specific histology subtype (Fetal), and a stage (II), all suggestive of hepatoblastoma.",
      "findings": [
        "large heterogeneous hepatic mass",
        "elevated AFP",
        "Fetal histology subtype",
        "PRETEXT stage II"
      ],
      "fracture_mentioned": null,
      "idx": 86,
      "timestamp": "2026-01-10T18:24:08.433032"
    },
    {
      "sample_idx": 87,
      "input": "16/12/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Acute Myeloid Leukemia.\n\nFrom clinical notes: Acute Myeloid Leukemia. Paediatric oncology assessment.\n\nFindings: myeloblasts accounting for 70% of marrow cellularity. Cytogenetic analysis reveals t(8;21) translocation. Favorable risk category. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 16/12/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"The report indicates 70% myeloblasts in the bone marrow and the presence of t(8;21) translocation, which are both indicators of acute myeloid leukemia (AML).\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"The report indicates 70% myeloblasts in the bone marrow and the presence of t(8;21) translocation, which are both indicators of acute myeloid leukemia (AML).\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"The report indicates 70% myeloblasts in the bone marrow and the presence of t(8;21) translocation, which are both indicators of acute myeloid leukemia (AML).\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"The report indicates 70% myeloblasts in the bone marrow and the presence of t(8;21) translocation, which are both indicators of acute myeloid leukemia (AML).\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        ",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report indicates 70% myeloblasts in the bone marrow and the presence of t(8;21) translocation, which are both indicators of acute myeloid leukemia (AML).",
      "findings": [
        "myeloblasts accounting for 70% of marrow cellularity",
        "t(8;21) translocation"
      ],
      "fracture_mentioned": null,
      "idx": 87,
      "timestamp": "2026-01-10T18:24:08.433042"
    },
    {
      "sample_idx": 88,
      "input": "29/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 29/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Stage II\"],\n        \"rationale\": \"The report mentions a large heterogeneous left renal mass with a pseudocapsule, which is suggestive of a Wilms Tumor. The report also mentions that the stage is II. This indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Stage II\"],\n        \"rationale\": \"The report mentions a large heterogeneous left renal mass with a pseudocapsule, which is suggestive of a Wilms Tumor. The report also mentions that the stage is II. This indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Stage II\"],\n        \"rationale\": \"The report mentions a large heterogeneous left renal mass with a pseudocapsule, which is suggestive of a Wilms Tumor. The report also mentions that the stage is II. This indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Stage II\"],\n        \"rationale\": \"The report mentions a large heterogeneous left renal mass with a pseudocapsule, which is suggestive of a Wilms Tumor. The report also mentions that the stage is II. This indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Stage II\"],\n        \"rationale\": \"The report mentions a large heterogeneous left renal mass with a pseudocapsule, which is suggestive of a Wilms Tumor. The report also mentions that the stage is II. This indicates malignancy.\"\n    }",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report mentions a large heterogeneous left renal mass with a pseudocapsule, which is suggestive of a Wilms Tumor. The report also mentions that the stage is II. This indicates malignancy.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 88,
      "timestamp": "2026-01-10T18:24:08.433053"
    },
    {
      "sample_idx": 89,
      "input": "16/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/01/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"CNS involvement negative\"],\n        \"rationale\": \"The report explicitly states bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells, and immunophenotyping consistent with B-cell ALL. CNS involvement is negative. These findings are highly suggestive of Acute Lymphoblastic Leukemia.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"CNS involvement negative\"],\n        \"rationale\": \"The report explicitly states bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells, and immunophenotyping consistent with B-cell ALL. CNS involvement is negative. These findings are highly suggestive of Acute Lymphoblastic Leukemia.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"CNS involvement negative\"],\n        \"rationale\": \"The report explicitly states bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells, and immunophenotyping consistent with B-cell ALL. CNS involvement is negative. These findings are highly suggestive of Acute Lymphoblastic Leukemia.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"CNS involvement negative\"],\n        \"rationale\": \"The report explicitly states bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells, and immunophenotyping consistent with B-cell ALL. CNS involvement is negative. These findings are highly suggestive of Acute Lymphoblastic",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly states bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells, and immunophenotyping consistent with B-cell ALL. CNS involvement is negative. These findings are highly suggestive of Acute Lymphoblastic Leukemia.",
      "findings": [
        "bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells",
        "Immunophenotyping consistent with B-cell ALL",
        "CNS involvement negative"
      ],
      "fracture_mentioned": null,
      "idx": 89,
      "timestamp": "2026-01-10T18:24:08.433066"
    },
    {
      "sample_idx": 90,
      "input": "06/09/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 06/09/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"Bilateral disease\", \"Family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report mentions intraocular masses with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, all of which are consistent with retinoblastoma, a type of eye cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"Bilateral disease\", \"Family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report mentions intraocular masses with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, all of which are consistent with retinoblastoma, a type of eye cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"Bilateral disease\", \"Family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report mentions intraocular masses with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, all of which are consistent with retinoblastoma, a type of eye cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"Bilateral disease\", \"Family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report mentions intraocular masses with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, all of which are consistent with retinoblastoma, a type of eye cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report mentions intraocular masses with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, all of which are consistent with retinoblastoma, a type of eye cancer.",
      "findings": [
        "intraocular mass with calcifications",
        "Bilateral disease",
        "Family history positive",
        "RB1 germline mutation detected"
      ],
      "fracture_mentioned": null,
      "idx": 90,
      "timestamp": "2026-01-10T18:24:08.433078"
    },
    {
      "sample_idx": 91,
      "input": "30/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 30/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates a healing fracture with normal bone density and no pathological features, thus ruling out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"ab",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report indicates a healing fracture with normal bone density and no pathological features, thus ruling out malignancy.",
      "findings": [
        "healing fracture",
        "normal bone density",
        "no pathological features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 91,
      "timestamp": "2026-01-10T18:24:08.433088"
    },
    {
      "sample_idx": 92,
      "input": "22/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 22/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign bone cyst - resolved\", \"No aggressive features\", \"Normal bone density\", \"No recurrence on imaging\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified and that the bone cyst is benign and resolved.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    ",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that no malignancy was identified and that the bone cyst is benign and resolved.",
      "findings": [
        "Benign bone cyst - resolved",
        "No aggressive features",
        "Normal bone density",
        "No recurrence on imaging",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 92,
      "timestamp": "2026-01-10T18:24:08.433099"
    },
    {
      "sample_idx": 93,
      "input": "04/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 04/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no pathological features or malignancy were identified. The healing fracture and normal bone density are also noted.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no pathological features or malignancy were identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no pathological features or malignancy were identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no pathological features or malignancy were identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no pathological features or malignancy were identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no pathological features or malignancy were identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that no pathological features or malignancy were identified. The healing fracture and normal bone density are also noted.",
      "findings": [
        "healing fracture",
        "normal bone density",
        "no pathological features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 93,
      "timestamp": "2026-01-10T18:24:08.433110"
    },
    {
      "sample_idx": 94,
      "input": "05/08/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 05/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the brain MRI was normal, and no mass lesion, abnormal enhancement, or malignancy was identified. Reassurance was provided.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the brain MRI was normal, and no mass lesion, abnormal enhancement, or malignancy was identified. Reassurance was provided.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the brain MRI was normal, and no mass lesion, abnormal enhancement, or malignancy was identified. Reassurance was provided.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the brain MRI was normal, and no mass lesion, abnormal enhancement, or malignancy was identified. Reassurance was provided.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that the brain MRI was normal, and no mass lesion, abnormal enhancement, or malignancy was identified. Reassurance was provided.",
      "findings": [
        "normal brain MRI",
        "no mass lesion",
        "no abnormal enhancement",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 94,
      "timestamp": "2026-01-10T18:24:08.433121"
    },
    {
      "sample_idx": 95,
      "input": "10/03/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 10/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"no pathological features\", \"normal bone density\", \"trauma history consistent\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features, no malignancy identified, and the fracture is healing normally. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features and no malignancy identified. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features and no malignancy identified. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features and no malignancy identified. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features and no malignancy identified. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features and no malignancy identified. Therefore, there",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that there are no pathological features, no malignancy identified, and the fracture is healing normally. Therefore, there is no evidence of malignancy.",
      "findings": [
        "healing fracture",
        "no pathological features",
        "normal bone density",
        "trauma history consistent",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 95,
      "timestamp": "2026-01-10T18:24:08.433132"
    },
    {
      "sample_idx": 96,
      "input": "28/09/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 28/09/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and confirms the diagnosis of Classical Hodgkin Lymphoma, nodular sclerosing type, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and confirms the diagnosis of Classical Hodgkin Lymphoma, nodular sclerosing type, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and confirms the diagnosis of Classical Hodgkin Lymphoma, nodular sclerosing type, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and confirms the diagnosis of Classical Hodgkin Lymphoma, nodular sclerosing type, indicating malignancy.\"\n    }\n}\n```\n```json",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and confirms the diagnosis of Classical Hodgkin Lymphoma, nodular sclerosing type, indicating malignancy.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 96,
      "timestamp": "2026-01-10T18:24:08.433144"
    },
    {
      "sample_idx": 97,
      "input": "02/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Brain Tumor - Glioma.\n\nFrom clinical notes: Brain Tumor - Glioma. Paediatric oncology assessment.\n\nFindings: left temporal lobe infiltrative mass with mass effect. FLAIR hyperintensity. Biopsy confirms diffuse astrocytoma WHO grade II. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 02/01/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"left temporal lobe infiltrative mass with mass effect\", \"FLAIR hyperintensity\", \"biopsy confirms diffuse astrocytoma WHO grade II\"],\n        \"rationale\": \"The report mentions an infiltrative mass in the left temporal lobe with mass effect and FLAIR hyperintensity, and a biopsy confirms a diffuse astrocytoma, which is a type of brain tumor. The WHO grade II classification indicates a less aggressive form of astrocytoma. Therefore, the findings suggest malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"left temporal lobe infiltrative mass with mass effect\", \"FLAIR hyperintensity\", \"biopsy confirms diffuse astrocytoma WHO grade II\"],\n        \"rationale\": \"The report mentions an infiltrative mass in the left temporal lobe with mass effect and FLAIR hyperintensity, and a biopsy confirms a diffuse astrocytoma, which is a type of brain tumor. The WHO grade II classification indicates a less aggressive form of astrocytoma. Therefore, the findings suggest malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"left temporal lobe infiltrative mass with mass effect\", \"FLAIR hyperintensity\", \"biopsy confirms diffuse astrocytoma WHO grade II\"],\n        \"rationale\": \"The report mentions an infiltrative mass in the left temporal lobe with mass effect and FLAIR hyperintensity, and a biopsy confirms a diffuse astrocytoma, which is a type of brain tumor. The WHO grade II classification indicates a less aggressive form of astrocytoma. Therefore, the findings suggest malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"left temporal lobe infiltrative mass with mass effect\", \"FLAIR hyperintensity\", \"biopsy confirms diffuse astrocytoma WHO grade II\"],\n        \"rationale\": \"The report mentions an infiltrative mass in the",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report mentions an infiltrative mass in the left temporal lobe with mass effect and FLAIR hyperintensity, and a biopsy confirms a diffuse astrocytoma, which is a type of brain tumor. The WHO grade II classification indicates a less aggressive form of astrocytoma. Therefore, the findings suggest malignancy.",
      "findings": [
        "left temporal lobe infiltrative mass with mass effect",
        "FLAIR hyperintensity",
        "biopsy confirms diffuse astrocytoma WHO grade II"
      ],
      "fracture_mentioned": null,
      "idx": 97,
      "timestamp": "2026-01-10T18:24:08.433158"
    },
    {
      "sample_idx": 98,
      "input": "29/06/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 29/06/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes normal blood counts with no blast cells, indicating no evidence of malignancy. The findings are reassuring.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes normal blood counts with no blast cells, indicating no evidence of malignancy. The findings are reassuring.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes normal blood counts with no blast cells, indicating no evidence of malignancy. The findings are reassuring.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes normal blood counts with no blast cells, indicating no evidence of malignancy. The findings are reassuring.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes normal blood counts with no blast cells, indicating no evidence of malignancy. The findings are reassuring.\"\n    }",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes normal blood counts with no blast cells, indicating no evidence of malignancy. The findings are reassuring.",
      "findings": [
        "normal CBC with age-appropriate values",
        "no blast cells",
        "platelets adequate",
        "hemoglobin within normal limits",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 98,
      "timestamp": "2026-01-10T18:24:08.433169"
    },
    {
      "sample_idx": 99,
      "input": "21/03/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"FDG-avid nodes\", \"nodular sclerosing type\"],\n        \"rationale\": \"The report describes mediastinal lymphadenopathy, FDG-avid nodes, and a nodular sclerosing type of Hodgkin Lymphoma, all of which indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"FDG-avid nodes\", \"nodular sclerosing type\"],\n        \"rationale\": \"The report describes mediastinal lymphadenopathy, FDG-avid nodes, and a nodular sclerosing type of Hodgkin Lymphoma, all of which indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"FDG-avid nodes\", \"nodular sclerosing type\"],\n        \"rationale\": \"The report describes mediastinal lymphadenopathy, FDG-avid nodes, and a nodular sclerosing type of Hodgkin Lymphoma, all of which indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"FDG-avid nodes\", \"nodular sclerosing type\"],\n        \"rationale\": \"The report describes mediastinal lymphadenopathy, FDG-avid nodes, and a nodular sclerosing type of Hodgkin Lymphoma, all of which indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"FDG-avid nodes\", \"nodular sclerosing type\"],\n        \"rationale\": \"The report describes mediastinal lymphadenopathy, FDG-avid nodes, and a nodular sclerosing type",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes mediastinal lymphadenopathy, FDG-avid nodes, and a nodular sclerosing type of Hodgkin Lymphoma, all of which indicate malignancy.",
      "findings": [
        "mediastinal lymphadenopathy",
        "FDG-avid nodes",
        "nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 99,
      "timestamp": "2026-01-10T18:24:08.433179"
    }
  ],
  "end_time": "2026-01-10T18:24:08.433611",
  "duration_seconds": 62.4598
}